%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Jean-Paul Viard, Alex Assuied, Yves Lévy, Jean-Claude Souberbielle, Rodolphe Thiébaut, Fabrice Carrat, Geneviève Chêne, Odile Launay, Laura Richert
No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 15 0 R/Contents 16 0 R/TrimBox[0 0 612 792]>>
endobj
15 0 obj
[17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R]
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref001)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref002)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref003)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref004)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref005)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref006)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref003)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref007)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref013)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref014)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref016)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref014)>>
endobj
29 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
16 0 obj
[31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R]
endobj
31 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 561.6145 m
199.9998 561.6145 l
199.9998 562.1145 l
575.9997 562.1145 l
f*
0.83 0.64 0.02 0 k
494.8157 510.9165 m
499.5213 510.9165 l
h
f*
375.4772 484.8945 m
380.2394 484.8945 l
h
f*
383.9244 380.9197 m
388.6866 380.9197 l
h
f*
371.5087 328.9323 m
376.2709 328.9323 l
h
f*
267.0236 302.9102 m
271.7858 302.9102 l
h
f*
274.0535 302.9102 m
278.8157 302.9102 l
h
f*
489.0898 250.9228 m
493.852 250.9228 l
h
f*
480.2457 224.9008 m
485.0079 224.9008 l
h
f*
490.2236 224.9008 m
499.6913 224.9008 l
h
f*
492.9449 198.9354 m
502.4693 198.9354 l
h
f*
507.6283 198.9354 m
517.1528 198.9354 l
h
f*
467.7165 172.9134 m
477.1843 172.9134 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(was)Tj
1.9812 0 Td
(43)Tj
1.3129 0 Td
(years,)Tj
2.9182 0 Td
(68%)Tj
2.202 0 Td
(were)Tj
2.3632 0 Td
(male,)Tj
2.6377 0 Td
(and)Tj
1.8679 0 Td
(7792%)Tj
3.8492 0 Td
(on)Tj
1.3128 0 Td
(antiretroviral)Tj
5.6514 0 Td
(treatment.)Tj
4.6846 0 Td
(Median)Tj
3.4613 0 Td
(25OHD)Tj
-34.2424 -1.474 Td
(level)Tj
2.2438 0 Td
(was)Tj
1.9812 0 Td
(18)Tj
1.3129 0 Td
(ng/mL)Tj
2.9779 0 Td
(\(IQR:)Tj
2.5959 0 Td
(1225\))Tj
3.2942 0 Td
(and)Tj
1.8678 0 Td
(24)Tj
1.3189 0 Td
(ng/mL)Tj
2.9719 0 Td
(\(IQR:)Tj
2.5959 0 Td
(1332\))Tj
3.2942 0 Td
(in)Tj
0.9846 0 Td
(the)Tj
1.5934 0 Td
(two)Tj
1.7664 0 Td
(trial)Tj
1.8023 0 Td
(populations,)Tj
-32.6013 -1.474 Td
(respectively.)Tj
5.717 0 Td
(In)Tj
1.0443 0 Td
(the)Tj
1.5934 0 Td
(multivariable)Tj
5.7588 0 Td
(model,)Tj
3.1867 0 Td
(there)Tj
2.4766 0 Td
(was)Tj
1.9812 0 Td
(no)Tj
1.3129 0 Td
(significant)Tj
4.607 0 Td
(association)Tj
5.1621 0 Td
(between)Tj
3.9565 0 Td
(base-)Tj
-36.7965 -1.474 Td
(line)Tj
1.7485 0 Td
(25OHD)Tj
3.5269 0 Td
(level)Tj
2.2438 0 Td
(and)Tj
1.8619 0 Td
(vaccine)Tj
3.5746 0 Td
(responses)Tj
4.7801 0 Td
(in)Tj
0.9847 0 Td
(ANRS)Tj
2.9778 0 Td
(HB03)Tj
2.6974 0 Td
(VIHVAC)Tj
3.9208 0 Td
(B)Tj
0.8832 0 Td
(\(proportional)Tj
5.7528 0 Td
(odds)Tj
2.3632 0 Td
(ratio)Tj
-37.3157 -1.474 Td
(0.83)Tj
2.1423 0 Td
(per)Tj
1.6471 0 Td
(10)Tj
1.3189 0 Td
(ng/mL)Tj
2.9719 0 Td
(25OHD)Tj
3.5268 0 Td
(increase;)Tj
4.2311 0 Td
(95%)Tj
2.2021 0 Td
(confidence)Tj
4.9949 0 Td
(interval)Tj
3.4016 0 Td
(0.651.07,)Tj
4.8934 0 Td
(p)Tj
0.7699 0 Td
(=)Tj
0.7996 0 Td
(0.14\).)Tj
2.7511 0 Td
(Explor-)Tj
-35.6507 -1.474 Td
(atory)Tj
2.4169 0 Td
(analyses)Tj
4.1236 0 Td
(of)Tj
1.0443 0 Td
(ANRS)Tj
2.9779 0 Td
(114-PNEUM)Tj
5.5678 0 Td
(OVAC)Tj
3.0376 0 Td
(showed)Tj
3.6283 0 Td
(consistent)Tj
4.6727 0 Td
(results.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 606.1039 cm
BT
/F3 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 589.096 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(This)Tj
2.0886 0 Td
(study)Tj
2.59 0 Td
(does)Tj
2.3632 0 Td
(not)Tj
1.5933 0 Td
(support)Tj
3.521 0 Td
(a)Tj
0.7698 0 Td
(positive)Tj
3.5627 0 Td
(association)Tj
5.162 0 Td
(between)Tj
3.9566 0 Td
(25OHD)Tj
3.5268 0 Td
(and)Tj
1.8679 0 Td
(immune)Tj
3.7417 0 Td
(responses)Tj
-34.7436 -1.474 Td
(to)Tj
1.0443 0 Td
(hepatitis)Tj
3.8969 0 Td
(B)Tj
0.8832 0 Td
(or)Tj
1.098 0 Td
(pneumococcal)Tj
6.5943 0 Td
(vaccination)Tj
5.162 0 Td
(in)Tj
0.9847 0 Td
(HIV-infected)Tj
5.6692 0 Td
(patients.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 529.0015 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 511.9937 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Vitamin)Tj
3.5489 0 Td
(D)Tj
0.9581 0 Td
(is)Tj
0.8447 0 Td
(increasingly)Tj
5.0287 0 Td
(recognized)Tj
4.5921 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(regulator)Tj
3.8607 0 Td
(of)Tj
1.0148 0 Td
(immune)Tj
3.6284 0 Td
(functions)Tj
3.9911 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5988 0 Td
(Innate)Tj
2.8119 0 Td
(and)Tj
1.7291 0 Td
(adap-)Tj
-35.2797 -1.2982 Td
(tive)Tj
1.661 0 Td
(immune)Tj
3.6284 0 Td
(cells)Tj
1.9218 0 Td
(harbour)Tj
3.464 0 Td
(the)Tj
1.4683 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9581 0 Td
(receptor,)Tj
3.7814 0 Td
(and)Tj
1.7292 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9524 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.8459 0 Td
(to)Tj
1.0262 0 Td
(play)Tj
1.8708 0 Td
(a)Tj
-35.5972 -1.3039 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(initial)Tj
2.5455 0 Td
(activation)Tj
4.1555 0 Td
(of)Tj
1.0148 0 Td
(na)Tj
/F14 1 Tf
[()]TJ
/F8 1 Tf
(ve)Tj
2.3358 0 Td
(T-cells)Tj
2.8799 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.6044 0 Td
(The)Tj
1.7802 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9525 0 Td
(receptor)Tj
3.5603 0 Td
(is)Tj
0.8447 0 Td
(involved)Tj
3.651 0 Td
(in)Tj
1.0375 0 Td
(regula-)Tj
-33.9475 -1.2983 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(gene)Tj
2.0806 0 Td
(expression)Tj
4.4617 0 Td
(and)Tj
1.7291 0 Td
(has)Tj
1.542 0 Td
(direct)Tj
2.5342 0 Td
(transcription)Tj
5.4311 0 Td
(activity,)Tj
3.3449 0 Td
(playing)Tj
3.1521 0 Td
(a)Tj
0.6576 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0319 0 Td
(physiological)Tj
-30.5913 -1.2983 Td
(processes)Tj
3.9684 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(cell)Tj
1.559 0 Td
(proliferation)Tj
5.2667 0 Td
(and)Tj
1.7292 0 Td
(differentiation.)Tj
6.2078 0 Td
(Moreover,)Tj
4.3937 0 Td
(antigen-presenting)Tj
7.7782 0 Td
(cells)Tj
1.9219 0 Td
(as)Tj
-35.8977 -1.2982 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(lymphocytes)Tj
5.2554 0 Td
(express)Tj
3.1407 0 Td
(the)Tj
1.4684 0 Td
(1-)Tj
/F15 1 Tf
()Tj
/F8 1 Tf
1.6157 0 Td
(hydroxylase)Tj
4.9946 0 Td
(to)Tj
1.0262 0 Td
(convert)Tj
3.2428 0 Td
(serum)Tj
2.7269 0 Td
(25-hydroxyvitamin)Tj
7.9199 0 Td
(D)Tj
-34.2252 -1.3039 Td
(\(25OHD\))Tj
4.0988 0 Td
(to)Tj
1.0262 0 Td
(its)Tj
1.1451 0 Td
(active)Tj
2.5229 0 Td
(form)Tj
2.2053 0 Td
(\(1,25-dihydroxvitamine)Tj
9.7228 0 Td
(D\),)Tj
1.525 0 Td
(resulting)Tj
3.7304 0 Td
(in)Tj
1.0318 0 Td
(local)Tj
2.0806 0 Td
(intra-)Tj
2.4888 0 Td
(and)Tj
1.7291 0 Td
(paracrine)Tj
-33.3068 -1.2983 Td
(actions.)Tj
3.2824 0 Td
(Studying)Tj
3.7871 0 Td
(the)Tj
1.4683 0 Td
(role)Tj
1.7689 0 Td
(of)Tj
1.0148 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9524 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.474 0 Td
(functions)Tj
3.9855 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(immune)Tj
3.6227 0 Td
(system)Tj
2.9366 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(active)Tj
-33.4202 -1.2983 Td
(field)Tj
1.9729 0 Td
(of)Tj
1.0147 0 Td
(research,)Tj
3.7814 0 Td
(and)Tj
1.7292 0 Td
(current)Tj
3.1861 0 Td
(knowledge)Tj
4.5411 0 Td
(indicates)Tj
3.77 0 Td
(that)Tj
1.7802 0 Td
(vitamin)Tj
3.3051 0 Td
(D)Tj
0.9581 0 Td
(has)Tj
1.5421 0 Td
(various)Tj
3.1407 0 Td
(immunomo-)Tj
-30.7216 -1.3039 Td
(dulatory)Tj
3.5829 0 Td
(effects,)Tj
2.9537 0 Td
(including)Tj
4.0422 0 Td
(actions)Tj
3.0614 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(innate)Tj
2.7382 0 Td
(immune)Tj
3.6284 0 Td
(system)Tj
2.9366 0 Td
(and)Tj
1.7292 0 Td
(orientating)Tj
4.6488 0 Td
(T-cellular)Tj
-32.0653 -1.2983 Td
(immune)Tj
3.6226 0 Td
(responses)Tj
4.0989 0 Td
(towards)Tj
3.4015 0 Td
(a)Tj
0.652 0 Td
(Th2)Tj
1.8368 0 Td
(phenotype)Tj
4.4391 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-16.8547 -1.2982 Td
(In)Tj
1.0998 0 Td
(epidemiological)Tj
6.5537 0 Td
(studies)Tj
2.9763 0 Td
(in)Tj
1.0262 0 Td
(the)Tj
1.4626 0 Td
(general)Tj
3.1238 0 Td
(population,)Tj
4.8018 0 Td
(25OHD)Tj
3.4129 0 Td
(deficiency)Tj
4.2576 0 Td
(has)Tj
1.5364 0 Td
(been)Tj
2.109 0 Td
(associated)Tj
-33.5563 -1.3039 Td
(with)Tj
1.9955 0 Td
(increased)Tj
4.0025 0 Td
(susceptibility)Tj
5.4368 0 Td
(to)Tj
1.0262 0 Td
(infections,)Tj
4.3766 0 Td
(particularly)Tj
4.8132 0 Td
(upper)Tj
2.5795 0 Td
(respiratory)Tj
4.5921 0 Td
(tract)Tj
2.0466 0 Td
(infections)Tj
4.1556 0 Td
(and)Tj
-35.0246 -1.2983 Td
(tuberculosis,)Tj
5.2667 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.652 0 Td
(meta-analysis)Tj
5.6522 0 Td
(suggested)Tj
4.0762 0 Td
(that)Tj
1.7745 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9581 0 Td
(supplementation)Tj
6.9562 0 Td
(offers)Tj
2.4605 0 Td
(some)Tj
2.33 0 Td
(pro-)Tj
-35.1663 -1.2983 Td
(tection)Tj
2.9876 0 Td
(against)Tj
3.0274 0 Td
(respiratory)Tj
4.5921 0 Td
(tract)Tj
2.0466 0 Td
(infections)Tj
4.1556 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.5987 0 Td
(In)Tj
1.1112 0 Td
(HIV-infected)Tj
5.5729 0 Td
(populations,)Tj
5.176 0 Td
(25OHD)Tj
3.4186 0 Td
(defi-)Tj
-33.6867 -1.2982 Td
(ciency)Tj
2.7609 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(unfavourable)Tj
5.4935 0 Td
(clinical)Tj
3.0728 0 Td
(evolution)Tj
4.0024 0 Td
(in)Tj
1.0375 0 Td
(both)Tj
2.058 0 Td
(ART-na)Tj
/F14 1 Tf
[()]TJ
/F8 1 Tf
(ve)Tj
4.6034 0 Td
(and)Tj
1.7291 0 Td
(ART-)Tj
-34.6731 -1.3039 Td
(treated)Tj
2.9933 0 Td
(patients)Tj
3.3676 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(],)Tj
2.3073 0 Td
(possibly)Tj
3.4413 0 Td
(through)Tj
3.4412 0 Td
(its)Tj
1.1452 0 Td
(effects)Tj
2.7269 0 Td
(on)Tj
1.2756 0 Td
(immunity.)Tj
-19.5022 -1.2983 Td
(In)Tj
1.1111 0 Td
(consequence,)Tj
5.5616 0 Td
(it)Tj
0.788 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(hypothesized)Tj
5.4709 0 Td
(that)Tj
1.7801 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(levels)Tj
2.3754 0 Td
(could)Tj
2.4491 0 Td
(have)Tj
2.0636 0 Td
(an)Tj
1.2019 0 Td
(impact)Tj
2.9821 0 Td
(on)Tj
-34.9056 -1.2983 Td
(immune)Tj
3.6226 0 Td
(responses)Tj
4.0989 0 Td
(to)Tj
1.0204 0 Td
(vaccines,)Tj
3.7814 0 Td
(mediated)Tj
3.9458 0 Td
(by)Tj
1.1792 0 Td
(its)Tj
1.1452 0 Td
(effects)Tj
2.7269 0 Td
(on)Tj
1.2756 0 Td
(immune)Tj
3.6284 0 Td
(homeostasis)Tj
5.0853 0 Td
(and)Tj
1.7291 0 Td
(immuno-)Tj
-33.2388 -1.3039 Td
(modulation.)Tj
5.125 0 Td
(Indeed,)Tj
3.2371 0 Td
(in)Tj
1.0375 0 Td
(mice,)Tj
2.3811 0 Td
(administration)Tj
6.1681 0 Td
(of)Tj
1.0148 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9524 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(adjuvant)Tj
3.702 0 Td
(during)Tj
2.931 0 Td
(vaccination)Tj
-32.0766 -1.2983 Td
(has)Tj
1.542 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(increase)Tj
3.4752 0 Td
(vaccine-induced)Tj
6.7918 0 Td
(immune)Tj
3.6227 0 Td
(responses)Tj
4.0932 0 Td
(\(reviewed)Tj
4.1385 0 Td
(in)Tj
1.0318 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(]\).)Tj
1.9446 0 Td
(In)Tj
1.1055 0 Td
(humans,)Tj
3.668 0 Td
(sev-)Tj
-35.2854 -1.2982 Td
(eral)Tj
1.6951 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.0579 0 Td
(shown)Tj
2.846 0 Td
(that)Tj
1.7801 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9524 0 Td
(level)Tj
2.0182 0 Td
(or)Tj
1.0942 0 Td
(supplementation)Tj
6.9619 0 Td
(does)Tj
2.0352 0 Td
(not)Tj
1.5761 0 Td
(influence)Tj
3.9174 0 Td
(the)Tj
-33.2331 -1.3039 Td
(response)Tj
3.7303 0 Td
(to)Tj
1.0262 0 Td
(influenza)Tj
3.9174 0 Td
(vaccination,)Tj
5.0513 0 Td
(including)Tj
4.0422 0 Td
(in)Tj
1.0375 0 Td
(HIV-infected)Tj
5.5728 0 Td
(persons)Tj
3.3052 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
3.0728 0 Td
(However,)Tj
4.0762 0 Td
(few)Tj
-34.8319 -1.2983 Td
(data)Tj
1.9105 0 Td
(are)Tj
1.4513 0 Td
(available)Tj
3.668 0 Td
(concerning)Tj
4.7452 0 Td
(the)Tj
1.4683 0 Td
(relationship)Tj
4.989 0 Td
(between)Tj
3.5319 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(level)Tj
2.0126 0 Td
(and)Tj
1.7348 0 Td
(vaccine)Tj
3.1918 0 Td
(responses)Tj
-32.9667 -1.2983 Td
(against)Tj
3.0273 0 Td
(other)Tj
2.3471 0 Td
(pathogens,)Tj
4.5297 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(hepatitis)Tj
3.617 0 Td
(B)Tj
0.7993 0 Td
(or)Tj
/F16 1 Tf
1.0942 0 Td
[()10()7()20()2()12()11()4()7()4()7()1()-4( )]TJ
5.4028 0 Td
[()11(\n)6()2()12()6()11(\n)18()4(\r)6()]TJ
/F8 1 Tf
5.0626 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
3.5433 0 Td
(In)Tj
1.1112 0 Td
(a)Tj
0.652 0 Td
(retro-)Tj
-34.2593 -1.3039 Td
(spective)Tj
3.3902 0 Td
(study)Tj
2.3867 0 Td
(in)Tj
1.0375 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(chronic)Tj
3.2882 0 Td
(kidney)Tj
2.9367 0 Td
(disease,)Tj
3.2484 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(deficiency)Tj
4.269 0 Td
(was)Tj
1.6951 0 Td
(found)Tj
2.6192 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
-35.5235 -1.2983 Td
(negatively)Tj
4.2349 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(seroconversion)Tj
6.2928 0 Td
(after)Tj
2.0353 0 Td
(hepatitis)Tj
3.617 0 Td
(B)Tj
0.7994 0 Td
(vaccine)Tj
3.1974 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
-25.2338 -1.2982 Td
(Correction)Tj
4.6034 0 Td
(of)Tj
1.0148 0 Td
(25OHD)Tj
3.4242 0 Td
(deficiency)Tj
4.2633 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(simple)Tj
2.8573 0 Td
(and)Tj
1.7291 0 Td
(harmless)Tj
3.7644 0 Td
(intervention.)Tj
5.4028 0 Td
(Demonstration)Tj
6.3382 0 Td
(of)Tj
-36.0961 -1.2983 Td
(an)Tj
1.2018 0 Td
(association)Tj
4.6261 0 Td
(between)Tj
3.532 0 Td
(25OHD)Tj
3.4186 0 Td
(deficiency)Tj
4.2689 0 Td
(and)Tj
1.7291 0 Td
(poor)Tj
2.1203 0 Td
(vaccine)Tj
3.1975 0 Td
(responses)Tj
4.0932 0 Td
(could)Tj
2.4548 0 Td
(thus)Tj
1.9332 0 Td
(lead)Tj
1.8538 0 Td
(to)Tj
1.0205 0 Td
(sup-)Tj
-35.4498 -1.3039 Td
(plementation)Tj
5.5502 0 Td
(trials)Tj
2.1996 0 Td
(aiming)Tj
3.0217 0 Td
(at)Tj
0.9525 0 Td
(improving)Tj
4.439 0 Td
(vaccine)Tj
3.1918 0 Td
(responses,)Tj
4.32 0 Td
(particularly)Tj
4.8132 0 Td
(in)Tj
1.0318 0 Td
(immuno-compro-)Tj
-29.5198 -1.2983 Td
(mised)Tj
2.6191 0 Td
(populations.)Tj
-1.4229 -1.2982 Td
(We)Tj
1.61 0 Td
(therefore)Tj
3.8551 0 Td
(examined)Tj
4.1272 0 Td
(whether)Tj
3.481 0 Td
(higher)Tj
2.8006 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4242 0 Td
(levels)Tj
2.3754 0 Td
(were)Tj
2.1203 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(better)Tj
-34.6731 -1.3039 Td
(responses)Tj
4.0932 0 Td
(to)Tj
1.0261 0 Td
(hepatitis)Tj
3.6113 0 Td
(B)Tj
0.7994 0 Td
(or)Tj
/F16 1 Tf
1.0998 0 Td
[()]TJ
/F8 1 Tf
(.)Tj
/F16 1 Tf
0.9014 0 Td
[()11(\n)6()2()12()6()11(\n)18()4(\r)6()]TJ
/F8 1 Tf
5.057 0 Td
(vaccination)Tj
4.8302 0 Td
(in)Tj
1.0318 0 Td
(two)Tj
1.7121 0 Td
(vaccine)Tj
3.1918 0 Td
(trials)Tj
2.1997 0 Td
(in)Tj
1.0375 0 Td
(HIV-infected)Tj
-30.5913 -1.2983 Td
(adults.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 379.6157 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.4937 0 Td
(D)Tj
0.9354 0 Td
(and)Tj
1.8567 0 Td
(Vaccine)Tj
3.7134 0 Td
(Response)Tj
4.4221 0 Td
(s)Tj
0.7158 0 Td
(in)Tj
0.9779 0 Td
(HIV-Infected)Tj
5.6977 0 Td
(Adults)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(640)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(15,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(10)Tj
ET
Q
q
0.83 0.64 0.02 0 k
1 j
1 J
0 w
120.9827 613.6441 m
157.4362 613.6441 l
h
f*
0 g
7.9999 0 0 7.9999 36 708.7181 cm
BT
/F11 1 Tf
1 TL
-0.025 Tc
0 0 Td
(reasons.)Tj
3.3874 0 Td
(The)Tj
1.5874 0 Td
(data)Tj
1.7858 0 Td
(are)Tj
1.3748 0 Td
(available)Tj
3.3804 0 Td
(upon)Tj
2.1118 0 Td
(request)Tj
2.9977 0 Td
(to)Tj
-16.6253 -1.3748 Td
(ANRS,)Tj
2.6716 0 Td
(the)Tj
1.3678 0 Td
(legal)Tj
1.9204 0 Td
(sponsor)Tj
3.267 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(trials,)Tj
2.2394 0 Td
(and)Tj
1.5874 0 Td
(written)Tj
-15.3709 -1.3748 Td
(requests)Tj
3.4157 0 Td
(may)Tj
1.8142 0 Td
(be)Tj
1.1197 0 Td
(sent)Tj
1.7858 0 Td
(to)Tj
0.9497 0 Td
(the)Tj
1.3748 0 Td
(corresp)Tj
2.8205 0 Td
(onding)Tj
2.785 0 Td
(author.)Tj
/F10 1 Tf
-16.0654 -2.126 Td
(Funding:)Tj
/F11 1 Tf
3.5716 0 Td
(ANRS)Tj
2.4449 0 Td
(HB03)Tj
2.2819 0 Td
(VIHVAC-B)Tj
3.9969 0 Td
(trial)Tj
1.5874 0 Td
(was)Tj
-13.8827 -1.3748 Td
(sponsored)Tj
4.1598 0 Td
(and)Tj
1.5874 0 Td
(funded)Tj
2.7922 0 Td
(by)Tj
1.1126 0 Td
(ANRS.)Tj
2.6717 0 Td
(Sanofi)Tj
2.5583 0 Td
(Pasteur-)Tj
-14.882 -1.3748 Td
(MSD)Tj
2.0834 0 Td
(provided)Tj
3.4583 0 Td
(the)Tj
1.3748 0 Td
(vaccines)Tj
3.4158 0 Td
(used)Tj
2.0055 0 Td
(in)Tj
0.8859 0 Td
(the)Tj
1.3748 0 Td
(trial.)Tj
1.8142 0 Td
(ANRS)Tj
-16.4127 -1.3748 Td
(114)Tj
1.637 0 Td
(Pneumovac)Tj
4.6063 0 Td
(trial)Tj
1.5945 0 Td
(was)Tj
1.7008 0 Td
(sponsored)Tj
4.1599 0 Td
(and)Tj
1.5874 0 Td
(funded)Tj
2.7921 0 Td
(by)Tj
-18.078 -1.3748 Td
(ANRS)Tj
2.4449 0 Td
(and)Tj
1.5874 0 Td
(realized)Tj
3.0118 0 Td
(with)Tj
1.7788 0 Td
(the)Tj
1.3748 0 Td
(support)Tj
3.0968 0 Td
(of)Tj
0.9497 0 Td
(Pfizer.)Tj
2.5016 0 Td
(This)Tj
-16.7458 -1.3748 Td
(study)Tj
2.2677 0 Td
(was)Tj
1.7008 0 Td
(funded)Tj
2.7921 0 Td
(by)Tj
1.1126 0 Td
(ANRS)Tj
2.4449 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(www.anr)Tj
3.6497 0 Td
(s.fr)Tj
0 g
(\).)Tj
1.963 0 Td
(The)Tj
-15.9308 -1.3749 Td
(funder)Tj
2.622 0 Td
(had)Tj
1.5874 0 Td
(no)Tj
1.1693 0 Td
(role)Tj
1.6158 0 Td
(in)Tj
0.8858 0 Td
(study)Tj
2.2678 0 Td
(design,)Tj
2.8984 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
-14.8394 -1.3748 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
3.4087 0 Td
(decision)Tj
3.2953 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1464 0 Td
(or)Tj
0.9993 0 Td
(preparation)Tj
4.4362 0 Td
(of)Tj
-17.8229 -1.3748 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F10 1 Tf
-1.3677 -2.126 Td
(Competing)Tj
4.3795 0 Td
(Interests)Tj
3.3307 0 Td
(:)Tj
/F11 1 Tf
0.4819 0 Td
(Sanofi)Tj
2.5583 0 Td
(Pasteur-MSD)Tj
-10.7504 -1.3748 Td
(provided)Tj
3.4582 0 Td
(the)Tj
1.3678 0 Td
(vaccines)Tj
3.4157 0 Td
(used)Tj
2.0127 0 Td
(in)Tj
0.8858 0 Td
(the)Tj
1.3677 0 Td
(ANRS)Tj
2.4449 0 Td
(HB03)Tj
-14.9528 -1.3748 Td
(VIHVAC-B)Tj
3.9968 0 Td
(trial)Tj
1.5874 0 Td
(that)Tj
1.63 0 Td
(was)Tj
1.7008 0 Td
(sponsored)Tj
4.1599 0 Td
(and)Tj
1.5874 0 Td
(funded)Tj
2.7921 0 Td
(by)Tj
-17.4544 -1.3748 Td
(ANRS.)Tj
2.6716 0 Td
(Pfizer)Tj
2.2819 0 Td
(provided)Tj
3.4583 0 Td
(support)Tj
3.0969 0 Td
(for)Tj
1.2543 0 Td
(the)Tj
1.3678 0 Td
(ANRS)Tj
2.4449 0 Td
(114)Tj
-16.5757 -1.3748 Td
(Pneumova)Tj
3.9614 0 Td
(c)Tj
0.6449 0 Td
(trial)Tj
1.5874 0 Td
(that)Tj
1.6299 0 Td
(was)Tj
1.7008 0 Td
(sponsored)Tj
4.1599 0 Td
(and)Tj
1.5874 0 Td
(funded)Tj
2.7922 0 Td
(by)Tj
-18.0639 -1.3749 Td
(ANRS.)Tj
2.6716 0 Td
(This)Tj
1.7788 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4173 0 Td
(alter)Tj
1.8213 0 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
-16.1788 -1.3748 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0048 0 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
BT
12.4087 -26.249 Td
(materials.)Tj
ET
Q
endstream
endobj
43 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 46 0 R/Contents 47 0 R/TrimBox[0 0 612 792]>>
endobj
46 0 obj
[48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R]
endobj
48 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref017)>>
endobj
49 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref018)>>
endobj
50 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref019)>>
endobj
51 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref020)>>
endobj
52 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref017)>>
endobj
53 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref021)>>
endobj
54 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref022)>>
endobj
55 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref023)>>
endobj
56 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref017)>>
endobj
57 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref017)>>
endobj
47 0 obj
[58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R]
endobj
58 0 obj
<>stream
q
0.83 0.64 0.02 0 k
304.7244 532.0063 m
314.2488 532.0063 l
h
f*
316.5165 532.0063 m
325.9843 532.0063 l
h
f*
263.7354 453.9969 m
273.2031 453.9969 l
h
f*
245.0835 428.0315 m
254.6079 428.0315 l
h
f*
203.4142 297.978 m
212.9386 297.978 l
h
f*
217.3606 297.978 m
226.885 297.978 l
h
f*
231.3071 297.978 m
240.8315 297.978 l
h
f*
276.7181 233.0079 m
286.2425 233.0079 l
h
f*
304.4409 194.0031 m
313.9654 194.0031 l
h
f*
363.7984 142.0157 m
373.3228 142.0157 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(Methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F8 1 Tf
1 TL
-0.01 Tc
0 0 Td
(This)Tj
1.9615 0 Td
(study)Tj
2.3584 0 Td
(used)Tj
2.0353 0 Td
(data)Tj
1.8935 0 Td
(from)Tj
2.1827 0 Td
(the)Tj
1.4513 0 Td
(randomized)Tj
5.0003 0 Td
(ANRS)Tj
2.7099 0 Td
(HB03)Tj
2.4945 0 Td
(VIHVAC)Tj
4.0308 0 Td
(B)Tj
0.7937 0 Td
(and)Tj
1.7121 0 Td
(ANRS)Tj
2.7156 0 Td
(114-PNEUMO)Tj
-31.3396 -1.3039 Td
(VAC)Tj
2.245 0 Td
(clinical)Tj
3.0274 0 Td
(trials)Tj
2.1599 0 Td
(in)Tj
1.0262 0 Td
(HIV-infected)Tj
5.4992 0 Td
(adults.)Tj
2.8006 0 Td
(The)Tj
1.7631 0 Td
(ANRS)Tj
2.7156 0 Td
(HB03)Tj
2.4945 0 Td
(VIHVAC)Tj
4.0251 0 Td
(B)Tj
0.7937 0 Td
(trial)Tj
1.8085 0 Td
(\(clinicaltrials.gov)Tj
-30.3588 -1.2982 Td
(NCT00480792\))Tj
6.3042 0 Td
(tested)Tj
2.5171 0 Td
(the)Tj
1.4513 0 Td
(immunogenicity)Tj
6.7748 0 Td
(of)Tj
0.9978 0 Td
(three)Tj
2.2393 0 Td
(or)Tj
1.0829 0 Td
(four)Tj
1.8935 0 Td
(doses)Tj
2.3698 0 Td
(of)Tj
1.0034 0 Td
(recombinant)Tj
5.3008 0 Td
(HBV)Tj
2.245 0 Td
(vaccine)Tj
-34.1799 -1.2983 Td
(\(three)Tj
2.5681 0 Td
(intramuscular)Tj
5.7713 0 Td
(20)Tj
/F14 1 Tf
1.1622 0 Td
[()]TJ
/F8 1 Tf
(g)Tj
1.1792 0 Td
(injections)Tj
4.0592 0 Td
(at)Tj
0.9411 0 Td
(W0,)Tj
1.8709 0 Td
(W4)Tj
1.6497 0 Td
(and)Tj
1.7121 0 Td
(W24;)Tj
2.3358 0 Td
(four)Tj
1.8878 0 Td
(intramuscular)Tj
5.777 0 Td
(40)Tj
/F14 1 Tf
1.1565 0 Td
[()]TJ
/F8 1 Tf
(g)Tj
1.1792 0 Td
(injections,)Tj
-33.2501 -1.3039 Td
(or)Tj
1.0828 0 Td
(four)Tj
1.8935 0 Td
(intradermal)Tj
4.8926 0 Td
(4)Tj
/F14 1 Tf
0.6916 0 Td
[()]TJ
/F8 1 Tf
(g)Tj
1.1792 0 Td
(injections)Tj
4.0649 0 Td
(at)Tj
0.9354 0 Td
(W0,)Tj
1.8709 0 Td
(W4,)Tj
1.8708 0 Td
(W8)Tj
1.6498 0 Td
(and)Tj
1.7121 0 Td
(W24\).)Tj
2.6702 0 Td
(The)Tj
1.7631 0 Td
(ANRS)Tj
2.7156 0 Td
(114-PNEUMOVAC)Tj
-28.9925 -1.2983 Td
(trial)Tj
1.8084 0 Td
(\(clinicaltrials.gov)Tj
6.9279 0 Td
(NCT00148824\))Tj
6.3042 0 Td
(evaluated)Tj
3.9401 0 Td
(two)Tj
1.6895 0 Td
(strategies)Tj
3.8607 0 Td
(of)Tj
1.0035 0 Td
(pneumococcal)Tj
5.9527 0 Td
(vaccination)Tj
-31.487 -1.2982 Td
(\(7-valent)Tj
3.736 0 Td
(conjugate)Tj
4.0535 0 Td
(vaccine)Tj
3.1521 0 Td
(at)Tj
0.9411 0 Td
(W0)Tj
1.6498 0 Td
(followed)Tj
3.5999 0 Td
(by)Tj
1.1679 0 Td
(23-valent)Tj
3.8721 0 Td
(polysaccharide)Tj
6.0548 0 Td
(vaccine)Tj
3.1521 0 Td
(at)Tj
0.9411 0 Td
(W4)Tj
1.6497 0 Td
(vs.)Tj
1.2473 0 Td
(one)Tj
-35.2174 -1.304 Td
(dose)Tj
2.0125 0 Td
(of)Tj
1.0035 0 Td
(the)Tj
1.4513 0 Td
(polysaccharide)Tj
6.0548 0 Td
(vaccine)Tj
3.1521 0 Td
(at)Tj
0.9411 0 Td
(W4)Tj
1.6497 0 Td
(without)Tj
3.2882 0 Td
(any)Tj
1.6384 0 Td
(vaccination)Tj
4.7622 0 Td
(at)Tj
0.9411 0 Td
(W0\).)Tj
-0.004 Tc
-25.6987 -1.2982 Td
(Each)Tj
2.177 0 Td
(trial)Tj
1.8368 0 Td
(was)Tj
1.7008 0 Td
(approved)Tj
3.9685 0 Td
(by)Tj
1.1848 0 Td
(the)Tj
1.4684 0 Td
(relevant)Tj
3.4185 0 Td
(ethics)Tj
2.5228 0 Td
(committee)Tj
4.5014 0 Td
(\(CPP)Tj
2.7326 0 Td
(Ile)Tj
1.2302 0 Td
(de)Tj
1.1736 0 Td
(France)Tj
2.948 0 Td
(3)Tj
1.0885 0 Td
(and)Tj
-33.1481 -1.2983 Td
(CCPPRB)Tj
4.2576 0 Td
(Cre)Tj
0 Tc
1.0544 0.051 Td
()Tj
-0.004 Tc
0.4026 -0.051 Td
(teil-Henri)Tj
4.1839 0 Td
(Mondor)Tj
3.9684 0 Td
(for)Tj
1.3833 0 Td
(ANRS)Tj
2.7383 0 Td
(HB03)Tj
2.5171 0 Td
(VIHVAC)Tj
4.0649 0 Td
(B)Tj
0.7994 0 Td
(and)Tj
1.7348 0 Td
(ANRS)Tj
2.7325 0 Td
(114-PNEUMO-)Tj
-29.8372 -1.2983 Td
(VAC,)Tj
2.4831 0 Td
(respectively\))Tj
5.2214 0 Td
(and)Tj
1.7291 0 Td
(was)Tj
1.6951 0 Td
(conducted)Tj
4.4277 0 Td
(in)Tj
1.0318 0 Td
(accordance)Tj
4.7338 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(Declaration)Tj
4.9096 0 Td
(of)Tj
1.0091 0 Td
(Helsinki.)Tj
3.8211 0 Td
(All)Tj
1.3947 0 Td
(par-)Tj
-35.9204 -1.3039 Td
(ticipants)Tj
3.6339 0 Td
(provided)Tj
3.8155 0 Td
(written)Tj
3.1124 0 Td
(informed)Tj
3.9741 0 Td
(consent.)Tj
3.5546 0 Td
(Methods)Tj
3.7588 0 Td
(and)Tj
1.7291 0 Td
(primary)Tj
3.4582 0 Td
(results)Tj
2.8063 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(trials)Tj
2.1997 0 Td
(have)Tj
-34.5257 -1.2982 Td
(been)Tj
2.1203 0 Td
(reported)Tj
3.6623 0 Td
(previously)Tj
4.3483 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
-8.9347 -1.2983 Td
(For)Tj
1.627 0 Td
(the)Tj
1.4684 0 Td
(current)Tj
3.1861 0 Td
(study,)Tj
2.6135 0 Td
(participants)Tj
4.9606 0 Td
(from)Tj
2.2054 0 Td
(each)Tj
2.0296 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(two)Tj
1.7121 0 Td
(trials)Tj
2.194 0 Td
(were)Tj
2.126 0 Td
(eligible)Tj
3.0614 0 Td
(if)Tj
0.7767 0 Td
(they)Tj
1.9275 0 Td
(had)Tj
1.7065 0 Td
(a)Tj
-35.2741 -1.3039 Td
(stored)Tj
2.7099 0 Td
(baseline)Tj
3.4299 0 Td
(plasma)Tj
3.033 0 Td
(sample)Tj
3.0217 0 Td
(\(from)Tj
2.5455 0 Td
(either)Tj
2.5285 0 Td
(trial)Tj
1.8368 0 Td
(screening)Tj
4.0536 0 Td
(or)Tj
1.0998 0 Td
(W0)Tj
1.6611 0 Td
(visit)Tj
1.8652 0 Td
(before)Tj
2.7439 0 Td
(vaccination\),)Tj
-30.5289 -1.2983 Td
(available)Tj
3.668 0 Td
(antibody)Tj
3.7587 0 Td
(data,)Tj
2.143 0 Td
(and)Tj
1.7291 0 Td
(if)Tj
0.7767 0 Td
(they)Tj
1.9218 0 Td
(had)Tj
1.7122 0 Td
(given)Tj
2.3754 0 Td
(informed)Tj
3.9741 0 Td
(consent)Tj
3.3335 0 Td
(for)Tj
1.3833 0 Td
(further)Tj
3.0274 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(their)Tj
2.109 0 Td
(sam-)Tj
-34.4577 -1.2982 Td
(ples.)Tj
1.9899 0 Td
(For)Tj
1.627 0 Td
(the)Tj
1.4684 0 Td
(ANRS)Tj
2.7382 0 Td
(114-PNEUMOVAC)Tj
8.2828 0 Td
(trial,)Tj
2.0636 0 Td
(an)Tj
1.2019 0 Td
(extra)Tj
2.211 0 Td
(eligibility)Tj
3.9288 0 Td
(criterion)Tj
3.6964 0 Td
(was)Tj
1.7007 0 Td
(consent)Tj
3.3279 0 Td
(to)Tj
1.0261 0 Td
(an)Tj
-35.2627 -1.304 Td
(immunological)Tj
6.2985 0 Td
(sub-study)Tj
4.1329 0 Td
(that)Tj
1.7801 0 Td
(assessed)Tj
3.4696 0 Td
(cellular)Tj
3.1408 0 Td
(CD4)Tj
2.0976 0 Td
(T-cell)Tj
2.5172 0 Td
(responses)Tj
4.0988 0 Td
(in)Tj
1.0318 0 Td
(addition)Tj
3.6 0 Td
(to)Tj
1.0261 0 Td
(antibody)Tj
-33.1934 -1.2982 Td
(measurements)Tj
6.032 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.075 0 Td
(25OHD)Tj
3.4242 0 Td
(was)Tj
1.6951 0 Td
(measured)Tj
4.1102 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(stored)Tj
2.7099 0 Td
(plasma)Tj
3.0331 0 Td
(samples)Tj
3.3789 0 Td
(from)Tj
2.2053 0 Td
(all)Tj
1.1452 0 Td
(eligible)Tj
3.0671 0 Td
(par-)Tj
-35.3818 -1.2983 Td
(ticipants)Tj
3.6339 0 Td
(of)Tj
1.0148 0 Td
(both)Tj
2.058 0 Td
(trials)Tj
2.1997 0 Td
(in)Tj
1.0374 0 Td
(a)Tj
0.652 0 Td
(single)Tj
2.5341 0 Td
(centralized)Tj
4.5921 0 Td
(laboratory)Tj
4.354 0 Td
(using)Tj
2.3868 0 Td
(the)Tj
1.474 0 Td
(DiaSorin)Tj
3.8267 0 Td
(radioimmunoassay)Tj
-29.7635 -1.2983 Td
(technique)Tj
4.1669 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(],)Tj
2.0749 0 Td
(which)Tj
2.6532 0 Td
(was)Tj
1.6951 0 Td
(calibrated)Tj
4.1556 0 Td
(against)Tj
3.0274 0 Td
(the)Tj
1.4683 0 Td
(NIST)Tj
2.3811 0 Td
(\(National)Tj
4.0365 0 Td
(Institutes)Tj
3.9401 0 Td
(of)Tj
1.0148 0 Td
(Standards)Tj
4.2009 0 Td
(and)Tj
-34.8148 -1.3039 Td
(Technology\))Tj
5.2724 0 Td
(standard.)Tj
3.9514 0 Td
(In)Tj
1.1055 0 Td
(descriptive)Tj
4.5581 0 Td
(analyses,)Tj
3.7077 0 Td
(25OHD)Tj
3.4186 0 Td
(level)Tj
2.0182 0 Td
(was)Tj
1.6951 0 Td
(categorized)Tj
4.7735 0 Td
(as)Tj
1.0148 0 Td
(sufficient)Tj
-31.5153 -1.2982 Td
(\()Tj
/F17 1 Tf
0 Tc
()Tj
/F8 1 Tf
-0.004 Tc
1.3322 0 Td
(30)Tj
1.1679 0 Td
(ng/mL\),)Tj
3.4866 0 Td
(insufficient)Tj
4.7281 0 Td
(\(1029)Tj
2.9821 0 Td
(ng/mL\))Tj
3.2598 0 Td
(and)Tj
1.7291 0 Td
(deficient)Tj
3.6907 0 Td
(\()Tj
/F18 1 Tf
0 Tc
(<)Tj
/F8 1 Tf
-0.004 Tc
(10)Tj
2.2847 0 Td
(ng/mL\).)Tj
-23.465 -1.2983 Td
(In)Tj
1.1055 0 Td
(the)Tj
1.4683 0 Td
(ANRS)Tj
2.7326 0 Td
(HB03)Tj
2.5171 0 Td
(VIHVAC)Tj
4.0592 0 Td
(B)Tj
0.7937 0 Td
(trial,)Tj
2.058 0 Td
(anti-HBs)Tj
3.8267 0 Td
(antibody)Tj
3.7587 0 Td
(responses)Tj
4.0876 0 Td
(to)Tj
1.0204 0 Td
(vaccination)Tj
4.8246 0 Td
(were)Tj
2.1203 0 Td
(mea-)Tj
-35.5689 -1.3039 Td
(sured)Tj
2.4321 0 Td
(at)Tj
0.9524 0 Td
(W28.)Tj
2.3584 0 Td
(As)Tj
1.2642 0 Td
(defined)Tj
/F16 1 Tf
3.2259 0 Td
[(\r)]TJ
0.7086 0 Td
[()11()-9()4()11()-9()]TJ
/F8 1 Tf
2.4151 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3925 0 Td
(protocol,)Tj
3.821 0 Td
(antibody)Tj
3.7644 0 Td
(responses)Tj
4.0932 0 Td
(levels)Tj
2.3754 0 Td
(were)Tj
2.126 0 Td
(treated)Tj
-34.435 -1.2983 Td
(as)Tj
1.0147 0 Td
(an)Tj
1.2019 0 Td
(ordered)Tj
3.3732 0 Td
(categorical)Tj
4.5128 0 Td
(endpoint)Tj
3.8551 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(statistical)Tj
3.9118 0 Td
(analyses,)Tj
3.7076 0 Td
(using)Tj
2.3868 0 Td
(the)Tj
1.474 0 Td
(following)Tj
3.9742 0 Td
(response)Tj
3.736 0 Td
(cate-)Tj
-35.6539 -1.2983 Td
(gories:)Tj
2.8402 0 Td
(hepatitis)Tj
3.6114 0 Td
(B)Tj
0.7993 0 Td
(vaccine)Tj
3.1975 0 Td
(non)Tj
1.8255 0 Td
(responders)Tj
4.6318 0 Td
(\(anti-HBs)Tj
/F17 1 Tf
0 Tc
4.1669 0 Td
()Tj
/F8 1 Tf
-0.004 Tc
0.9921 0 Td
(10)Tj
1.1679 0 Td
(mIU/mL\),)Tj
4.371 0 Td
(low)Tj
1.6554 0 Td
(responders)Tj
4.6318 0 Td
(\(10)Tj
-33.8908 -1.3039 Td
(mIU/mL)Tj
/F18 1 Tf
0 Tc
3.804 0 Td
(<)Tj
/F8 1 Tf
-0.004 Tc
0.9921 0 Td
(anti-HBs)Tj
/F17 1 Tf
0 Tc
3.8268 0 Td
()Tj
/F8 1 Tf
-0.004 Tc
0.9921 0 Td
(100)Tj
1.6441 0 Td
(mIU/mL\))Tj
4.1442 0 Td
(and)Tj
1.7291 0 Td
(high)Tj
2.007 0 Td
(responders)Tj
4.6317 0 Td
(\(anti-HBs)Tj
/F18 1 Tf
0 Tc
4.1669 0 Td
(>)Tj
/F8 1 Tf
-0.004 Tc
0.9922 0 Td
(100)Tj
1.6497 0 Td
(mIU/mL\).)Tj
4.3653 0 Td
(The)Tj
-34.9452 -1.2982 Td
(cut-off)Tj
2.9026 0 Td
(of)Tj
1.0148 0 Td
(10)Tj
1.1679 0 Td
(mIU/mL)Tj
3.804 0 Td
(reflects)Tj
3.0558 0 Td
(an)Tj
1.2019 0 Td
(anti-HBs)Tj
3.8267 0 Td
(titer)Tj
1.8822 0 Td
(level)Tj
2.0126 0 Td
(consistent)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(seroprotection,)Tj
6.2702 0 Td
(while)Tj
2.3697 0 Td
(the)Tj
-35.7616 -1.2983 Td
(100)Tj
1.644 0 Td
(mIU/mL)Tj
3.8041 0 Td
(cut-off)Tj
2.9027 0 Td
(is)Tj
0.8504 0 Td
(considered)Tj
4.5977 0 Td
(to)Tj
1.0262 0 Td
(confer)Tj
2.7836 0 Td
(higher)Tj
2.8006 0 Td
(and)Tj
1.7291 0 Td
(long-term)Tj
4.2519 0 Td
(protection)Tj
4.3824 0 Td
(against)Tj
3.0274 0 Td
(infection)Tj
-33.8001 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7347 0 Td
(21)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.3947 0 Td
(22)Tj
0 g
(].)Tj
1.7404 0 Td
(Associations)Tj
5.2384 0 Td
(between)Tj
3.5263 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4242 0 Td
(level,)Tj
2.2394 0 Td
(treated)Tj
2.999 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(quantitative)Tj
4.9776 0 Td
(variable,)Tj
3.583 0 Td
(and)Tj
-35.9544 -1.2983 Td
(ordered)Tj
3.3732 0 Td
(antibody)Tj
3.7643 0 Td
(response)Tj
3.7304 0 Td
(levels)Tj
2.3754 0 Td
(were)Tj
2.1203 0 Td
(analyzed)Tj
3.7021 0 Td
(in)Tj
1.0374 0 Td
(proportional)Tj
5.3121 0 Td
(odds)Tj
2.143 0 Td
(models)Tj
3.1068 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(ANRS)Tj
-33.1708 -1.2982 Td
(HB03)Tj
2.5171 0 Td
(VIHVAC)Tj
4.0649 0 Td
(B)Tj
0.7993 0 Td
(trial,)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(its)Tj
1.1452 0 Td
(sample)Tj
3.0217 0 Td
(size)Tj
1.6838 0 Td
(was)Tj
1.7008 0 Td
(sufficiently)Tj
4.6147 0 Td
(large.)Tj
2.3811 0 Td
(This)Tj
1.9899 0 Td
(model)Tj
2.744 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.6519 0 Td
(generalization)Tj
-31.2432 -1.2983 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(logistic)Tj
3.0557 0 Td
(model)Tj
2.7439 0 Td
(for)Tj
1.3833 0 Td
(an)Tj
1.2076 0 Td
(ordered)Tj
3.3675 0 Td
(categorical)Tj
4.5184 0 Td
(response)Tj
3.7304 0 Td
(variable)Tj
3.3562 0 Td
(instead)Tj
3.0841 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(binary)Tj
2.8006 0 Td
(variable,)Tj
-33.3975 -1.3039 Td
(and)Tj
1.7291 0 Td
(estimated)Tj
4.0705 0 Td
(proportional)Tj
5.3121 0 Td
(odds)Tj
2.1486 0 Td
(ratios)Tj
2.4548 0 Td
(reflect)Tj
2.6929 0 Td
(the)Tj
1.474 0 Td
(odds)Tj
2.143 0 Td
(of)Tj
1.0148 0 Td
(being)Tj
2.4321 0 Td
(in)Tj
1.0318 0 Td
(any)Tj
1.6611 0 Td
(higher)Tj
2.8006 0 Td
(antibody)Tj
-30.9654 -1.2983 Td
(response)Tj
3.7303 0 Td
(category)Tj
3.6 0 Td
([)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
1.7859 0 Td
(randomized)Tj
5.0569 0 Td
(arms)Tj
2.2054 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(trial)Tj
1.8368 0 Td
(were)Tj
2.126 0 Td
(pooled)Tj
2.948 0 Td
(for)Tj
1.3833 0 Td
(these)Tj
2.2564 0 Td
(analyses)Tj
3.4809 0 Td
(but)Tj
-34.9679 -1.2983 Td
(multivariable)Tj
5.5161 0 Td
(models)Tj
3.1068 0 Td
(were)Tj
2.1203 0 Td
(used,)Tj
2.2847 0 Td
(adjusting)Tj
3.9061 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(trial)Tj
1.8369 0 Td
(arms)Tj
2.2053 0 Td
(and)Tj
1.7291 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(following)Tj
3.9798 0 Td
(clinical,)Tj
-32.3997 -1.3039 Td
(behavioural)Tj
4.9209 0 Td
(and)Tj
1.7291 0 Td
(socio-demographic)Tj
7.9199 0 Td
(determinants)Tj
5.5389 0 Td
(of)Tj
1.0148 0 Td
(vaccine)Tj
3.1975 0 Td
(responses)Tj
4.0932 0 Td
(reported)Tj
3.6623 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4683 0 Td
(pri-)Tj
-34.5767 -1.2982 Td
(mary)Tj
2.296 0 Td
(analyses)Tj
3.4866 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(trial)Tj
1.8369 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(]:)Tj
2.0749 0 Td
(sex,)Tj
1.6951 0 Td
(age,)Tj
1.7688 0 Td
(active)Tj
2.5228 0 Td
(smoking)Tj
3.6851 0 Td
(status,)Tj
2.7269 0 Td
(baseline)Tj
3.4299 0 Td
(CD4)Tj
2.0919 0 Td
(count)Tj
2.5285 0 Td
(and)Tj
1.7291 0 Td
(plasma)Tj
-34.3556 -1.2983 Td
(HIV-1)Tj
2.8459 0 Td
(RNA.)Tj
2.4888 0 Td
(Adequacy)Tj
4.2009 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(proportional)Tj
5.3121 0 Td
(odds)Tj
2.1429 0 Td
(assumption)Tj
4.8643 0 Td
(was)Tj
1.7007 0 Td
(checked)Tj
3.464 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.6519 0 Td
(score)Tj
2.3074 0 Td
(test.)Tj
-34.8545 -1.3039 Td
(We)Tj
1.61 0 Td
(further)Tj
3.0274 0 Td
(performed)Tj
4.4674 0 Td
(sensitivity)Tj
4.2236 0 Td
(analyses,)Tj
3.7077 0 Td
(using)Tj
2.3867 0 Td
(a)Tj
0.6577 0 Td
(binary)Tj
2.8006 0 Td
(anti-HBs)Tj
3.8267 0 Td
(antibody)Tj
3.7644 0 Td
(response)Tj
3.7304 0 Td
(defini-)Tj
-34.2026 -1.2983 Td
(tion)Tj
1.8425 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(logistic)Tj
3.0501 0 Td
(regression)Tj
4.3199 0 Td
(model,)Tj
2.9707 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(cut-off)Tj
2.9027 0 Td
(of)Tj
1.0148 0 Td
(10)Tj
1.1679 0 Td
(mIU/mL)Tj
3.804 0 Td
(as)Tj
1.0148 0 Td
(done)Tj
2.228 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(primary)Tj
3.4583 0 Td
(end-)Tj
-34.6221 -1.2983 Td
(point)Tj
2.3584 0 Td
(analysis)Tj
3.3221 0 Td
(of)Tj
1.0205 0 Td
(the)Tj
1.4683 0 Td
(original)Tj
3.3222 0 Td
(trial)Tj
1.8369 0 Td
(report)Tj
2.7099 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
-14.8421 -1.3039 Td
(Power)Tj
2.7666 0 Td
(calculations)Tj
4.9379 0 Td
(under)Tj
2.6192 0 Td
(the)Tj
1.4683 0 Td
(simplified)Tj
4.2066 0 Td
(and)Tj
1.7291 0 Td
(conservative)Tj
5.1874 0 Td
(assumption)Tj
4.8585 0 Td
(of)Tj
1.0205 0 Td
(a)Tj
0.652 0 Td
(binary)Tj
2.8006 0 Td
(25OHD)Tj
-33.4429 -1.2982 Td
(explanatory)Tj
4.9209 0 Td
(variable)Tj
3.3562 0 Td
(\(dichotomized)Tj
6.0661 0 Td
(by)Tj
1.1848 0 Td
(the)Tj
1.4684 0 Td
(median\))Tj
3.5829 0 Td
(indicated)Tj
3.9345 0 Td
(that)Tj
1.7802 0 Td
(the)Tj
1.4683 0 Td
(ANRS)Tj
2.7382 0 Td
(HB03)Tj
2.5172 0 Td
(VIHVAC)Tj
-33.0177 -1.2983 Td
(B)Tj
0.7993 0 Td
(dataset)Tj
2.9934 0 Td
(would)Tj
2.7156 0 Td
(provide)Tj
3.2881 0 Td
(at)Tj
0.9525 0 Td
(least)Tj
1.9842 0 Td
(80%)Tj
1.9275 0 Td
(power)Tj
2.7213 0 Td
(to)Tj
1.0261 0 Td
(detect)Tj
2.6135 0 Td
(a)Tj
0.6577 0 Td
(univariable)Tj
4.6998 0 Td
(proportional)Tj
5.3121 0 Td
(odds)Tj
2.143 0 Td
(ratio)Tj
2.0976 0 Td
(of)Tj
-35.9317 -1.2983 Td
(1.7)Tj
1.3946 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(two-sided)Tj
4.1669 0 Td
(type)Tj
1.9105 0 Td
(1)Tj
0.6974 0 Td
(error)Tj
2.2677 0 Td
(rate)Tj
1.7461 0 Td
(of)Tj
1.0148 0 Td
(5%.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 379.6157 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.4937 0 Td
(D)Tj
0.9354 0 Td
(and)Tj
1.8567 0 Td
(Vaccine)Tj
3.7134 0 Td
(Response)Tj
4.4221 0 Td
(s)Tj
0.7158 0 Td
(in)Tj
0.9779 0 Td
(HIV-Infected)Tj
5.6977 0 Td
(Adults)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(640)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(15,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
BT
66.402 0 Td
(10)Tj
ET
Q
endstream
endobj
67 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 68 0 R/Contents 69 0 R/TrimBox[0 0 612 792]>>
endobj
68 0 obj
[70 0 R 71 0 R 72 0 R 73 0 R 74 0 R]
endobj
70 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref019)>>
endobj
71 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref019)>>
endobj
72 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref019)>>
endobj
73 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.t001)>>
endobj
74 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref017)>>
endobj
69 0 obj
[75 0 R 76 0 R 77 0 R 78 0 R 79 0 R]
endobj
75 0 obj
<>stream
q
0.83 0.64 0.02 0 k
277.5685 615.3449 m
287.0362 615.3449 l
h
f*
526.9606 511.3134 m
536.485 511.3134 l
h
f*
529.852 342.3118 m
539.3764 342.3118 l
h
f*
370.0346 198.9354 m
399.2882 198.9354 l
h
f*
470.0976 185.8961 m
479.5654 185.8961 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 211.9748 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(ANRS)Tj
2.7382 0 Td
(114-PNEUMOVAC)Tj
8.2828 0 Td
(sub-study)Tj
4.1329 0 Td
(anti-pneumococcal)Tj
7.9199 0 Td
(IgG)Tj
1.7405 0 Td
(antibody)Tj
3.7644 0 Td
(measure-)Tj
-32.3544 -1.3039 Td
(ments)Tj
2.6702 0 Td
(were)Tj
2.1203 0 Td
(performed)Tj
4.473 0 Td
(at)Tj
0.9524 0 Td
(W8,)Tj
1.8822 0 Td
(and)Tj
1.7348 0 Td
(cellular)Tj
3.1351 0 Td
(CD4)Tj
2.0976 0 Td
(T-cell)Tj
2.5229 0 Td
(responses)Tj
4.0932 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(diphtheria-derived)Tj
7.7272 0 Td
(car-)Tj
-35.9033 -1.2982 Td
(rier)Tj
1.6497 0 Td
(protein)Tj
3.1578 0 Td
(CRM)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 269.8582 679.748 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(197)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 282.7275 681.3921 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(conjugate)Tj
4.1045 0 Td
(anti-pneumococcal)Tj
7.92 0 Td
(vaccine)Tj
3.1918 0 Td
(were)Tj
2.1259 0 Td
(measured)Tj
4.1102 0 Td
(at)Tj
0.9468 0 Td
(W0,)Tj
1.8879 0 Td
(W4)Tj
-35.0416 -1.2982 Td
(and)Tj
1.7291 0 Td
(W24.)Tj
2.3641 0 Td
(Antibody)Tj
4.0138 0 Td
(levels)Tj
2.3754 0 Td
(to)Tj
1.0261 0 Td
(each)Tj
2.0239 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(7)Tj
0.6917 0 Td
(serotypes)Tj
3.9401 0 Td
(shared)Tj
2.863 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(7-valent)Tj
3.4526 0 Td
(conjugate)Tj
4.1045 0 Td
(and)Tj
-33.7263 -1.2983 Td
(23-valent)Tj
3.9175 0 Td
(polysaccharide)Tj
6.1283 0 Td
(vaccine)Tj
3.1861 0 Td
(\(serotypes)Tj
4.269 0 Td
(4,)Tj
0.9127 0 Td
(6B,)Tj
1.4967 0 Td
(9V,)Tj
1.6044 0 Td
(14,)Tj
1.389 0 Td
(18C,)Tj
2.0523 0 Td
(19F,)Tj
1.9162 0 Td
(and)Tj
1.7234 0 Td
(23F\))Tj
2.0296 0 Td
(were)Tj
2.1147 0 Td
(determined.)Tj
-32.7399 -1.3039 Td
(Per)Tj
1.5704 0 Td
(participant)Tj
4.5978 0 Td
(and)Tj
1.7291 0 Td
(serotype,)Tj
3.8039 0 Td
(presence)Tj
3.7134 0 Td
(of)Tj
1.0148 0 Td
(antibody)Tj
3.7644 0 Td
(response)Tj
3.7304 0 Td
(was)Tj
1.7007 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(participant)Tj
4.5978 0 Td
(who)Tj
-34.4633 -1.2983 Td
(experienced)Tj
5.0343 0 Td
(both)Tj
2.0579 0 Td
(a)Tj
0.6577 0 Td
(2-fold)Tj
2.6134 0 Td
(post-vaccination)Tj
6.8598 0 Td
(antibody)Tj
3.7644 0 Td
(increase)Tj
3.4696 0 Td
(and)Tj
1.7348 0 Td
(a)Tj
0.6519 0 Td
(level)Tj
2.0126 0 Td
(of)Tj
1.0148 0 Td
(serotype)Tj
3.5773 0 Td
(specific)Tj
-33.4485 -1.2982 Td
(IgG)Tj
1.7405 0 Td
(of)Tj
/F17 1 Tf
0 Tc
1.0148 0 Td
()Tj
/F8 1 Tf
-0.004 Tc
(1)Tj
1.4683 0 Td
(mg/mL)Tj
3.1918 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0748 0 Td
(IgG)Tj
1.7405 0 Td
(response)Tj
3.736 0 Td
(to)Tj
1.0205 0 Td
(vaccination)Tj
4.8302 0 Td
(at)Tj
0.9524 0 Td
(W8)Tj
1.6611 0 Td
(was)Tj
1.6951 0 Td
(summarized)Tj
5.1874 0 Td
(according)Tj
4.1896 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
-35.5235 -1.3039 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(pneumococcal)Tj
6.0206 0 Td
(serotypes)Tj
3.9345 0 Td
(\(02,)Tj
2.2563 0 Td
(34,)Tj
1.9106 0 Td
(57\))Tj
2.0296 0 Td
(a)Tj
0.6576 0 Td
(participant)Tj
4.5921 0 Td
(developed)Tj
4.2746 0 Td
(a)Tj
0.652 0 Td
(response)Tj
3.736 0 Td
(to.)Tj
1.2473 0 Td
(Cel-)Tj
-35.7446 -1.2983 Td
(lular)Tj
2.0466 0 Td
(responses)Tj
4.0932 0 Td
(were)Tj
2.1203 0 Td
(analyzed)Tj
3.7019 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(group)Tj
2.6079 0 Td
(having)Tj
2.9197 0 Td
(received)Tj
3.5319 0 Td
(the)Tj
1.4684 0 Td
(7-valent)Tj
3.4525 0 Td
(conjugate)Tj
4.1046 0 Td
(vaccine)Tj
-32.5528 -1.2983 Td
(prime)Tj
2.6192 0 Td
(containing)Tj
4.5241 0 Td
(the)Tj
1.4739 0 Td
(diphtheria-derived)Tj
7.7272 0 Td
(carrier)Tj
2.88 0 Td
(protein)Tj
3.1521 0 Td
(CRM)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 445.5496 575.7165 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(197,)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 460.1196 577.4173 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(and)Tj
1.7291 0 Td
(included)Tj
3.7133 0 Td
(lymphocyte)Tj
-31.4529 -1.3039 Td
(proliferative)Tj
5.0853 0 Td
(responses)Tj
4.0989 0 Td
(\(expressed)Tj
4.4334 0 Td
(as)Tj
1.0148 0 Td
(stimulation)Tj
4.7961 0 Td
(index,)Tj
2.6759 0 Td
(i.e.)Tj
1.3607 0 Td
(counts)Tj
2.8855 0 Td
(per)Tj
1.5307 0 Td
(minute)Tj
3.1068 0 Td
(in)Tj
1.0374 0 Td
(stimulated)Tj
4.422 0 Td
(vs.)Tj
-36.4475 -1.2982 Td
(unstimulated)Tj
5.4992 0 Td
(cultures\))Tj
3.7417 0 Td
(and)Tj
1.7291 0 Td
(Th1-associated)Tj
6.2192 0 Td
(T-cell)Tj
2.5228 0 Td
(cytokine)Tj
3.6397 0 Td
(responses)Tj
4.0931 0 Td
(\(production)Tj
5.0569 0 Td
(of)Tj
1.0148 0 Td
(interleu-)Tj
-33.5165 -1.2983 Td
(kin-2)Tj
2.3584 0 Td
(or)Tj
1.0942 0 Td
(interferon-gamma,)Tj
7.8179 0 Td
(measured)Tj
4.1102 0 Td
(in)Tj
1.0318 0 Td
(supernatants\))Tj
5.6863 0 Td
(after)Tj
2.0352 0 Td
(stimulation)Tj
4.7961 0 Td
(of)Tj
1.0148 0 Td
(peripheral)Tj
4.32 0 Td
(blood)Tj
-34.2649 -1.3039 Td
(mononuclear)Tj
5.5729 0 Td
(cells)Tj
1.9219 0 Td
(with)Tj
2.0012 0 Td
(the)Tj
1.4683 0 Td
(conjugated)Tj
4.6318 0 Td
(carrier)Tj
2.88 0 Td
(protein)Tj
3.1521 0 Td
(CRM)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 438.0661 523.7291 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(197)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 450.9921 525.3732 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(or)Tj
1.0941 0 Td
(with)Tj
2.0013 0 Td
(diphtheria)Tj
4.3766 0 Td
(toxin.)Tj
-32.5697 -1.2982 Td
(Details)Tj
2.9877 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(laboratory)Tj
4.3483 0 Td
(methods)Tj
3.685 0 Td
(for)Tj
1.389 0 Td
(these)Tj
2.2507 0 Td
(assays)Tj
2.6248 0 Td
(have)Tj
2.0637 0 Td
(been)Tj
2.1203 0 Td
(previously)Tj
4.3482 0 Td
(described)Tj
4.0535 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
-31.1581 -1.2983 Td
(The)Tj
1.7858 0 Td
(associations)Tj
4.9889 0 Td
(between)Tj
3.5263 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4242 0 Td
(and)Tj
1.7292 0 Td
(immune)Tj
3.6283 0 Td
(responses)Tj
4.0931 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(ANRS)Tj
-30.3077 -1.2982 Td
(114-PNEUMOVAC)Tj
8.2771 0 Td
(sub-study,)Tj
4.3596 0 Td
(which)Tj
2.6532 0 Td
(had)Tj
1.7065 0 Td
(a)Tj
0.6576 0 Td
(small)Tj
2.3244 0 Td
(sample)Tj
3.0217 0 Td
(size)Tj
1.6838 0 Td
(\(n)Tj
1.1111 0 Td
(=)Tj
0.7993 0 Td
(25\))Tj
1.5137 0 Td
(available)Tj
3.6624 0 Td
(for)Tj
1.3889 0 Td
(the)Tj
1.4684 0 Td
(present)Tj
-34.6277 -1.304 Td
(analyses,)Tj
3.7076 0 Td
(were)Tj
2.1204 0 Td
(assessed)Tj
3.4695 0 Td
(by)Tj
1.1792 0 Td
(non-parametric)Tj
6.531 0 Td
(tests)Tj
1.9616 0 Td
(\(Kruskal-Wallis)Tj
6.5365 0 Td
(test)Tj
1.6044 0 Td
(and)Tj
1.7235 0 Td
(Spearman)Tj
4.2463 0 Td
(rank)Tj
2.0692 0 Td
(corre-)Tj
-35.1492 -1.2982 Td
(lations\))Tj
3.2201 0 Td
(instead)Tj
3.0784 0 Td
(of)Tj
1.0148 0 Td
(regression)Tj
4.32 0 Td
(models.)Tj
3.3335 0 Td
(Acknowledging)Tj
6.5083 0 Td
(the)Tj
1.4683 0 Td
(limited)Tj
3.067 0 Td
(statistical)Tj
3.9118 0 Td
(power)Tj
2.7212 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(small)Tj
-35.1266 -1.2983 Td
(sample)Tj
3.0217 0 Td
(size,)Tj
1.9105 0 Td
(we)Tj
1.3266 0 Td
(used)Tj
2.058 0 Td
(this)Tj
1.6724 0 Td
(independent)Tj
5.2781 0 Td
(dataset)Tj
2.9933 0 Td
(for)Tj
1.389 0 Td
(exploratory)Tj
4.8132 0 Td
(analyses)Tj
3.4865 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5172 0 Td
(whether)Tj
3.4809 0 Td
(the)Tj
-34.9735 -1.3039 Td
(overall)Tj
2.9026 0 Td
(signals)Tj
2.9027 0 Td
(were)Tj
2.1203 0 Td
(consistent)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.474 0 Td
(conclusions)Tj
4.9379 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(ANRS)Tj
2.7381 0 Td
(HB03)Tj
2.5228 0 Td
(VIHVAC)Tj
4.0649 0 Td
(B)Tj
0.7994 0 Td
(trial's)Tj
-34.3896 -1.2983 Td
(analyses.)Tj
3.7076 0 Td
(We)Tj
1.6101 0 Td
(furthermore)Tj
5.1477 0 Td
(explored)Tj
3.702 0 Td
(potential)Tj
3.7587 0 Td
(associations)Tj
4.989 0 Td
(between)Tj
3.5318 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4186 0 Td
(level)Tj
2.0182 0 Td
(and)Tj
-35.3136 -1.2982 Td
(the)Tj
1.4683 0 Td
(cellular)Tj
3.1408 0 Td
(immune)Tj
3.6226 0 Td
(response)Tj
3.7361 0 Td
(measurements)Tj
6.032 0 Td
(available)Tj
3.6624 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(ANRS)Tj
2.7381 0 Td
(114-PNEUMOVAC)Tj
8.2828 0 Td
(sub-)Tj
-35.1889 -1.304 Td
(study.)Tj
2.6135 0 Td
(Spearman)Tj
4.2463 0 Td
(correlations)Tj
4.9776 0 Td
(between)Tj
3.5262 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4243 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4682 0 Td
(change)Tj
3.0444 0 Td
(in)Tj
1.0375 0 Td
(cellular)Tj
3.1351 0 Td
(responses)Tj
-32.6321 -1.2982 Td
(after)Tj
2.0352 0 Td
(vaccination)Tj
4.8246 0 Td
(were)Tj
2.1203 0 Td
(assessed)Tj
3.4752 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(group)Tj
2.6079 0 Td
(having)Tj
2.9196 0 Td
(received)Tj
3.532 0 Td
(the)Tj
1.4682 0 Td
(7-valent)Tj
3.4526 0 Td
(conjugate)Tj
4.1045 0 Td
(vaccine)Tj
-33.0459 -1.2983 Td
(prime)Tj
2.6192 0 Td
(containing)Tj
4.524 0 Td
(the)Tj
1.474 0 Td
(diphtheria-derived)Tj
7.7272 0 Td
(carrier)Tj
2.88 0 Td
(protein)Tj
3.1521 0 Td
(CRM)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 445.5496 367.7102 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(197)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 458.4188 369.411 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(at)Tj
0.9524 0 Td
(W0)Tj
1.6611 0 Td
(\(n)Tj
1.1112 0 Td
(=)Tj
0.7993 0 Td
(11\).)Tj
1.7348 0 Td
(For)Tj
1.6271 0 Td
(these)Tj
-33.7263 -1.2982 Td
(analyses,)Tj
3.7077 0 Td
(change)Tj
3.0444 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(given)Tj
2.3754 0 Td
(cellular)Tj
3.1408 0 Td
(response)Tj
3.7304 0 Td
(was)Tj
1.7007 0 Td
(calculated)Tj
4.2066 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(individual)Tj
4.2859 0 Td
(difference)Tj
4.2066 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
-35.6085 -1.3039 Td
(level)Tj
2.0126 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(response)Tj
3.736 0 Td
(between)Tj
3.5263 0 Td
(W0)Tj
1.6611 0 Td
(to)Tj
1.0261 0 Td
(W4)Tj
1.6611 0 Td
(\(the)Tj
1.8085 0 Td
(peak)Tj
2.092 0 Td
(time)Tj
2.0296 0 Td
(point)Tj
2.3584 0 Td
(of)Tj
1.0148 0 Td
(cellular)Tj
3.1407 0 Td
(responses)Tj
4.0932 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(]\),)Tj
2.4151 0 Td
(i.e.)Tj
-35.0586 -1.2983 Td
(the)Tj
1.4683 0 Td
(W0)Tj
1.6611 0 Td
(value)Tj
2.3074 0 Td
(was)Tj
1.7008 0 Td
(subtracted)Tj
4.388 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.474 0 Td
(W4)Tj
1.6611 0 Td
(value,)Tj
2.5285 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(log)Tj
1.44 0 Td
(stimulation)Tj
4.7904 0 Td
(index)Tj
2.4548 0 Td
(and)Tj
1.7291 0 Td
(for)Tj
1.389 0 Td
(inter-)Tj
-34.0551 -1.2983 Td
(feron-)Tj
/F15 1 Tf
(\r)Tj
/F8 1 Tf
3.1634 0 Td
(and)Tj
1.7292 0 Td
(interleukin-2)Tj
5.4651 0 Td
(levels)Tj
2.3754 0 Td
(in)Tj
1.0375 0 Td
(supernatants.)Tj
5.5672 0 Td
(Given)Tj
2.6305 0 Td
(the)Tj
1.4684 0 Td
(limited)Tj
3.067 0 Td
(statistical)Tj
3.9117 0 Td
(power,)Tj
2.9481 0 Td
(search)Tj
2.7609 0 Td
(for)Tj
-36.1244 -1.3039 Td
(any)Tj
1.6554 0 Td
(signals)Tj
2.9027 0 Td
(focussed)Tj
3.6396 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(direction)Tj
3.8551 0 Td
(of)Tj
1.0148 0 Td
(effects)Tj
2.7269 0 Td
(more)Tj
2.3415 0 Td
(than)Tj
2.0295 0 Td
(on)Tj
1.2756 0 Td
(p-values.)Tj
-22.9888 -1.2982 Td
(Data)Tj
2.126 0 Td
(from)Tj
2.2053 0 Td
(each)Tj
2.0296 0 Td
(trial)Tj
1.8368 0 Td
(were)Tj
2.1203 0 Td
(analyzed)Tj
3.7021 0 Td
(separately,)Tj
4.4106 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(available)Tj
3.6679 0 Td
(data.)Tj
2.1373 0 Td
(Analyses)Tj
3.7361 0 Td
(were)Tj
2.1203 0 Td
(per-)Tj
-35.0359 -1.2983 Td
(formed)Tj
3.1578 0 Td
(using)Tj
2.3867 0 Td
(SAS)Tj
1.8539 0 Td
(software,)Tj
3.8154 0 Td
(version)Tj
3.1521 0 Td
(9.3)Tj
1.3946 0 Td
(\(SAS)Tj
2.1997 0 Td
(Institute,)Tj
3.8041 0 Td
(Cary,)Tj
2.3697 0 Td
(North)Tj
2.6645 0 Td
(Carolina\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 242.9858 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 225.9779 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Out)Tj
1.7914 0 Td
(of)Tj
1.0148 0 Td
(426)Tj
1.6498 0 Td
(participants)Tj
4.9549 0 Td
(randomized)Tj
5.057 0 Td
(and)Tj
1.7348 0 Td
(vaccinated)Tj
4.4503 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(ANRS)Tj
2.7382 0 Td
(HB03)Tj
2.5228 0 Td
(VIHVAC)Tj
4.0592 0 Td
(B)Tj
0.805 0 Td
(trial,)Tj
2.058 0 Td
(339)Tj
-35.3421 -1.2982 Td
(fulfilled)Tj
3.2768 0 Td
(the)Tj
1.474 0 Td
(eligibility)Tj
3.9288 0 Td
(criteria)Tj
3.0727 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(present)Tj
3.1635 0 Td
(study)Tj
2.3867 0 Td
(and)Tj
1.7291 0 Td
(were)Tj
2.126 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4683 0 Td
(analyses.)Tj
3.7134 0 Td
(Their)Tj
-33.5733 -1.2983 Td
(baseline)Tj
3.4298 0 Td
(characteristics)Tj
5.9074 0 Td
(are)Tj
1.4457 0 Td
(summarized)Tj
5.1873 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0318 0 Td
(Table)Tj
2.4435 0 Td
(1)Tj
0 g
0.6973 0 Td
(and)Tj
1.7291 0 Td
(there)Tj
2.2621 0 Td
(were)Tj
2.1259 0 Td
(no)Tj
1.2756 0 Td
(clinically)Tj
3.7757 0 Td
(relevant)Tj
3.4186 0 Td
(differ-)Tj
-34.7298 -1.3039 Td
(ences)Tj
2.398 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.474 0 Td
(baseline)Tj
3.4299 0 Td
(characteristics)Tj
5.9017 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(entire)Tj
2.5512 0 Td
(trial)Tj
1.8368 0 Td
(population)Tj
4.5921 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.075 0 Td
(The)Tj
1.7801 0 Td
(median)Tj
3.2428 0 Td
(baseline)Tj
-33.766 -1.2983 Td
(25OHD)Tj
3.4185 0 Td
(level)Tj
2.0069 0 Td
(was)Tj
1.7008 0 Td
(18)Tj
1.1679 0 Td
(ng/mL)Tj
2.914 0 Td
(\(IQR:)Tj
2.4944 0 Td
(1225\),)Tj
3.1975 0 Td
(with)Tj
1.9956 0 Td
(17%)Tj
1.9275 0 Td
(of)Tj
1.0092 0 Td
(patients)Tj
3.3675 0 Td
(having)Tj
2.914 0 Td
(sufficient)Tj
3.9061 0 Td
(25OHD)Tj
3.4186 0 Td
(levels)Tj
-35.4385 -1.2982 Td
(\()Tj
/F17 1 Tf
0 Tc
()Tj
/F8 1 Tf
-0.004 Tc
1.3322 0 Td
(30)Tj
1.1679 0 Td
(ng/mL\),)Tj
3.4866 0 Td
(70%)Tj
1.9275 0 Td
(having)Tj
2.9197 0 Td
(insufficient)Tj
4.7282 0 Td
(levels)Tj
2.3754 0 Td
(\(1029)Tj
2.982 0 Td
(ng/mL\))Tj
3.2598 0 Td
(and)Tj
1.7291 0 Td
(13%)Tj
1.9276 0 Td
(having)Tj
2.9197 0 Td
(deficiency)Tj
4.2689 0 Td
(\()Tj
/F18 1 Tf
0 Tc
(<)Tj
/F8 1 Tf
-0.004 Tc
1.3266 0 Td
(10)Tj
-36.3512 -1.2983 Td
(ng/mL\).)Tj
3.4865 0 Td
(A)Tj
0.9015 0 Td
(higher)Tj
2.8062 0 Td
(proportion)Tj
4.6318 0 Td
(of)Tj
1.0148 0 Td
(participants)Tj
4.9549 0 Td
(living)Tj
2.4718 0 Td
(in)Tj
1.0318 0 Td
(Northern)Tj
4.0082 0 Td
(France)Tj
2.948 0 Td
(had)Tj
1.7065 0 Td
(25OHD)Tj
3.4242 0 Td
(levels)Tj
-33.3862 -1.3039 Td
(below)Tj
2.5851 0 Td
(30ng/mL)Tj
3.8721 0 Td
(compared)Tj
4.2463 0 Td
(to)Tj
1.0261 0 Td
(participants)Tj
4.955 0 Td
(living)Tj
2.4718 0 Td
(in)Tj
1.0318 0 Td
(Southern)Tj
3.9004 0 Td
(France)Tj
2.948 0 Td
(\(88%)Tj
2.2734 0 Td
(vs.)Tj
1.2586 0 Td
(72%,)Tj
2.1543 0 Td
(p)Tj
/F18 1 Tf
0 Tc
(<)Tj
/F8 1 Tf
-0.004 Tc
(0.001\).)Tj
-32.7229 -1.2983 Td
(Likewise,)Tj
3.9061 0 Td
(the)Tj
1.4683 0 Td
(proportion)Tj
4.6318 0 Td
(of)Tj
1.0148 0 Td
(25OHD)Tj
3.4242 0 Td
(levels)Tj
2.3754 0 Td
(below)Tj
2.5852 0 Td
(30ng/mL)Tj
3.8721 0 Td
(was)Tj
1.7008 0 Td
(higher)Tj
2.8006 0 Td
(in)Tj
1.0375 0 Td
(participants)Tj
4.9549 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
-35.773 -1.2982 Td
(baseline)Tj
3.4298 0 Td
(sample)Tj
3.0218 0 Td
(collected)Tj
3.736 0 Td
(in)Tj
1.0375 0 Td
(winter/spring)Tj
5.6749 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0261 0 Td
(participants)Tj
4.9606 0 Td
(whose)Tj
2.7213 0 Td
(sample)Tj
3.0217 0 Td
(was)Tj
1.7008 0 Td
(col-)Tj
-34.5711 -1.304 Td
(lected)Tj
2.5625 0 Td
(in)Tj
1.0374 0 Td
(summer/fall)Tj
5.0853 0 Td
(\(94%)Tj
2.2678 0 Td
(vs.)Tj
1.2585 0 Td
(75%,)Tj
2.1543 0 Td
(p)Tj
/F18 1 Tf
0 Tc
(<)Tj
/F8 1 Tf
-0.004 Tc
(0.001\).)Tj
4.201 0 Td
(There)Tj
2.5795 0 Td
(was)Tj
1.7008 0 Td
(no)Tj
1.2755 0 Td
(significant)Tj
4.388 0 Td
(association)Tj
4.6261 0 Td
(between)Tj
-33.1367 -1.2982 Td
(baseline)Tj
3.4298 0 Td
(body)Tj
2.2167 0 Td
(mass)Tj
2.194 0 Td
(index)Tj
2.4548 0 Td
(\(BMI\))Tj
2.7099 0 Td
(and)Tj
1.7291 0 Td
(25OHD)Tj
3.4243 0 Td
(levels.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 379.6157 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.4937 0 Td
(D)Tj
0.9354 0 Td
(and)Tj
1.8567 0 Td
(Vaccine)Tj
3.7134 0 Td
(Response)Tj
4.4221 0 Td
(s)Tj
0.7158 0 Td
(in)Tj
0.9779 0 Td
(HIV-Infected)Tj
5.6977 0 Td
(Adults)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(640)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(15,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(4)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
76 0 obj
<>stream
endstream
endobj
77 0 obj
<>stream
endstream
endobj
78 0 obj
<>stream
endstream
endobj
79 0 obj
<>stream
BT
66.402 0 Td
(10)Tj
ET
Q
endstream
endobj
80 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 83 0 R/Contents 84 0 R/TrimBox[0 0 612 792]>>
endobj
83 0 obj
[85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R]
endobj
85 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.t002)>>
endobj
86 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.t003)>>
endobj
87 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.t003)>>
endobj
88 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.ref016)>>
endobj
89 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168640.t001)>>
endobj
90 0 obj
<>/Border[0 0 0]/Dest(Lpone.0168640.t001)>>
endobj
91 0 obj
<>/Border[0 0 0]/Dest(Lpone.0168640.t002)>>
endobj
84 0 obj
[92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R]
endobj
92 0 obj
<>stream
q
0.83 0.64 0.02 0 k
478.2614 489.7134 m
507.4016 489.7134 l
h
f*
372.3024 450.7087 m
401.5559 450.7087 l
h
f*
387.326 385.7386 m
416.5228 385.7386 l
416.5228 385.6819 l
387.326 385.6819 l
f*
438.9732 372.6992 m
448.4976 372.6992 l
h
f*
454.337 255.685 m
483.4772 255.685 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 211.9748 503.7732 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(There)Tj
2.5795 0 Td
(was)Tj
1.7007 0 Td
(no)Tj
1.2756 0 Td
(statistically)Tj
4.6091 0 Td
(significant)Tj
4.388 0 Td
(association)Tj
4.6261 0 Td
(between)Tj
3.532 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4185 0 Td
(status)Tj
2.5002 0 Td
(\(suffi-)Tj
-33.2558 -1.2982 Td
(ciency,)Tj
2.9876 0 Td
(insufficiency)Tj
5.3065 0 Td
(and)Tj
1.7291 0 Td
(deficiency\))Tj
4.6091 0 Td
(and)Tj
1.7291 0 Td
(vaccine)Tj
3.1918 0 Td
(response)Tj
3.736 0 Td
(categories)Tj
4.1953 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7779 0 Td
(2)Tj
0 g
(,)Tj
0.9241 0 Td
(Chi-squared)Tj
-31.1865 -1.2983 Td
(test)Tj
1.5987 0 Td
(p)Tj
0.737 0 Td
(=)Tj
0.7993 0 Td
(0.09\).)Tj
-1.9388 -1.3039 Td
(Baseline)Tj
3.5035 0 Td
(25OHD)Tj
3.4243 0 Td
(levels)Tj
2.3754 0 Td
(assessed)Tj
3.4696 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(continuous)Tj
4.7338 0 Td
(variable)Tj
3.3619 0 Td
(also)Tj
1.7631 0 Td
(did)Tj
1.5421 0 Td
(not)Tj
1.576 0 Td
(significantly)Tj
5.091 0 Td
(differ)Tj
-33.7093 -1.2983 Td
(between)Tj
3.5262 0 Td
(the)Tj
1.4684 0 Td
(antibody)Tj
3.7643 0 Td
(response)Tj
3.7361 0 Td
(groups)Tj
2.9707 0 Td
(\(see)Tj
0.83 0.64 0.02 0 k
1.7631 0 Td
(Table)Tj
2.4435 0 Td
(3)Tj
0 g
0.6973 0 Td
(for)Tj
1.3833 0 Td
(median)Tj
3.2428 0 Td
(25OHD)Tj
3.4242 0 Td
(levels)Tj
2.3754 0 Td
(per)Tj
1.5307 0 Td
(antibody)Tj
-32.326 -1.2982 Td
(response)Tj
3.7303 0 Td
(group,)Tj
2.8346 0 Td
(Kruskal)Tj
3.3336 0 Td
(Wallis)Tj
2.7382 0 Td
(test)Tj
1.5987 0 Td
(p)Tj
0.737 0 Td
(=)Tj
0.7994 0 Td
(0.12\).)Tj
-14.5756 -1.3039 Td
(The)Tj
1.7858 0 Td
(univariable)Tj
4.6998 0 Td
(regression)Tj
4.32 0 Td
(analysis)Tj
3.3278 0 Td
(indicated)Tj
3.9345 0 Td
(a)Tj
0.6576 0 Td
(marginally)Tj
4.5071 0 Td
(significant)Tj
4.388 0 Td
(association)Tj
4.6261 0 Td
(between)Tj
-33.4429 -1.2983 Td
(lower)Tj
2.4491 0 Td
(25OHD)Tj
3.4242 0 Td
(levels)Tj
2.3754 0 Td
(and)Tj
1.7291 0 Td
(better)Tj
2.5399 0 Td
(vaccine)Tj
3.1974 0 Td
(response)Tj
3.7304 0 Td
(\(proportional)Tj
5.6522 0 Td
(odds)Tj
2.143 0 Td
(ratio)Tj
2.0976 0 Td
(of)Tj
1.0205 0 Td
(having)Tj
2.914 0 Td
(a)Tj
0.652 0 Td
(better)Tj
-33.9248 -1.2983 Td
(antibody)Tj
3.7643 0 Td
(response)Tj
3.7304 0 Td
(category,)Tj
3.8267 0 Td
(per)Tj
1.5307 0 Td
(10)Tj
1.1679 0 Td
(ng/mL)Tj
2.9253 0 Td
(increase)Tj
3.4696 0 Td
(in)Tj
1.0375 0 Td
(25OHD:)Tj
3.6453 0 Td
(0.78)Tj
1.8709 0 Td
([95%)Tj
2.2734 0 Td
(confidence)Tj
4.5977 0 Td
(interval:)Tj
-33.8397 -1.2982 Td
(0.620.98,)Tj
4.2632 0 Td
(P)Tj
0.7824 0 Td
(=)Tj
0.7993 0 Td
(0.03\).)Tj
2.4378 0 Td
(In)Tj
1.1112 0 Td
(multivariable)Tj
5.5162 0 Td
(analyses)Tj
3.4809 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7836 0 Td
(3)Tj
0 g
(\),)Tj
1.2586 0 Td
(taking)Tj
2.7326 0 Td
(into)Tj
1.8368 0 Td
(account)Tj
3.3845 0 Td
(all)Tj
1.1452 0 Td
(determinants)Tj
-31.5323 -1.304 Td
(associated)Tj
4.2575 0 Td
(with)Tj
1.9956 0 Td
(vaccine)Tj
3.1918 0 Td
(response)Tj
3.7361 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(original)Tj
3.3278 0 Td
(trial)Tj
1.8369 0 Td
(report)Tj
2.7042 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(],)Tj
2.0806 0 Td
(no)Tj
1.2756 0 Td
(significant)Tj
4.388 0 Td
(association)Tj
4.6261 0 Td
(was)Tj
-35.926 -1.2982 Td
(found)Tj
2.6191 0 Td
(between)Tj
3.5263 0 Td
(baseline)Tj
3.4299 0 Td
(25OHD)Tj
3.4242 0 Td
(level)Tj
2.0126 0 Td
(and)Tj
1.7291 0 Td
(antibody)Tj
3.7644 0 Td
(response)Tj
3.7361 0 Td
(category)Tj
3.5943 0 Td
(\(proportional)Tj
5.6522 0 Td
(odds)Tj
-33.4882 -1.2983 Td
(ratio:)Tj
2.3243 0 Td
(0.83)Tj
1.8709 0 Td
(per)Tj
1.5307 0 Td
(10)Tj
1.1735 0 Td
(ng/mL)Tj
2.9197 0 Td
(increase)Tj
3.4696 0 Td
(of)Tj
1.0148 0 Td
(25OHD,)Tj
3.651 0 Td
(95%)Tj
1.9275 0 Td
(confidence)Tj
4.5978 0 Td
(interval:)Tj
3.4922 0 Td
(0.651.07,)Tj
4.269 0 Td
(p)Tj
0.737 0 Td
(=)Tj
0.7994 0 Td
(0.14\).)Tj
-33.7774 -1.3039 Td
(Sensitivity)Tj
4.3369 0 Td
(analyses,)Tj
3.7077 0 Td
(using)Tj
2.3868 0 Td
(a)Tj
0.6576 0 Td
(binary)Tj
2.8006 0 Td
(anti-HBs)Tj
3.8268 0 Td
(antibody)Tj
3.7643 0 Td
(response)Tj
3.7304 0 Td
(definition)Tj
4.1669 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6577 0 Td
(logistic)Tj
3.0557 0 Td
(regres-)Tj
-34.1232 -1.2983 Td
(sion)Tj
1.9048 0 Td
(model,)Tj
2.965 0 Td
(showed)Tj
3.2542 0 Td
(consistent)Tj
4.2576 0 Td
(conclusions)Tj
4.9379 0 Td
(regarding)Tj
4.0932 0 Td
(the)Tj
1.4684 0 Td
(absence)Tj
3.3448 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(association)Tj
4.6261 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(mul-)Tj
-35.5745 -1.2982 Td
(tivariable)Tj
3.9231 0 Td
(model.)Tj
2.9707 0 Td
(We)Tj
1.6044 0 Td
(further)Tj
3.033 0 Td
(tested)Tj
2.5512 0 Td
(for)Tj
1.3833 0 Td
(an)Tj
1.2018 0 Td
(interaction)Tj
4.6092 0 Td
(between)Tj
3.5262 0 Td
(baseline)Tj
3.4356 0 Td
(25OHD)Tj
3.4186 0 Td
(and)Tj
1.7291 0 Td
(vaccine)Tj
-33.3862 -1.3039 Td
(dose)Tj
2.0352 0 Td
(group)Tj
2.6135 0 Td
(on)Tj
1.2756 0 Td
(antibody)Tj
3.7644 0 Td
(responses)Tj
4.0932 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(multivariable)Tj
5.5162 0 Td
(proportional)Tj
5.3121 0 Td
(odds)Tj
2.143 0 Td
(model)Tj
2.7439 0 Td
(and)Tj
1.7291 0 Td
(found)Tj
2.6192 0 Td
(no)Tj
-36.3512 -1.2983 Td
(significant)Tj
4.3879 0 Td
(interaction.)Tj
-3.1917 -1.2983 Td
(Among)Tj
3.2484 0 Td
(the)Tj
1.4684 0 Td
(60)Tj
1.1735 0 Td
(ANRS)Tj
2.7326 0 Td
(114-PNEUMOVAC)Tj
8.2828 0 Td
(sub-study)Tj
4.1329 0 Td
(participants,)Tj
5.1873 0 Td
(25)Tj
1.1679 0 Td
(could)Tj
2.4548 0 Td
(be)Tj
1.1508 0 Td
(included)Tj
3.7077 0 Td
(in)Tj
-35.9033 -1.3039 Td
(the)Tj
1.4683 0 Td
(present)Tj
3.1634 0 Td
(analyses.)Tj
3.7077 0 Td
(Their)Tj
2.4208 0 Td
(baseline)Tj
3.4299 0 Td
(characteristics)Tj
5.9073 0 Td
(are)Tj
1.4457 0 Td
(shown)Tj
2.8516 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0375 0 Td
(Table)Tj
2.4378 0 Td
(1)Tj
0 g
(.)Tj
0.9241 0 Td
(Median)Tj
3.3108 0 Td
(baseline)Tj
-32.1049 -1.2983 Td
(25OHD)Tj
3.4185 0 Td
(level)Tj
2.0183 0 Td
(was)Tj
1.6951 0 Td
(24)Tj
1.1735 0 Td
(ng/mL)Tj
2.9197 0 Td
(\(IQR:)Tj
2.4944 0 Td
(1332\),)Tj
3.2032 0 Td
(with)Tj
2.0012 0 Td
(32%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(having)Tj
2.9197 0 Td
(sufficient)Tj
3.9117 0 Td
(levels,)Tj
2.5966 0 Td
(56%)Tj
-34.6618 -1.2982 Td
(having)Tj
2.9139 0 Td
(insufficient)Tj
4.7282 0 Td
(levels)Tj
2.3754 0 Td
(and)Tj
1.7348 0 Td
(12%)Tj
1.9276 0 Td
(having)Tj
2.9139 0 Td
(deficiency.)Tj
ET
Q
q
0.45 0.36 0.35 0.01 k
1 j
1 J
0 w
36 703.8893 m
576 703.8893 l
576 703.3893 l
36 703.3893 l
f*
200.6558 703.3893 m
200.6558 690.3893 l
200.1557 690.8893 l
200.1557 703.3893 l
f*
200.6558 690.3893 m
36 690.3893 l
36 690.8893 l
200.1557 690.8893 l
f*
375.0911 703.3893 m
375.0911 690.3893 l
374.5911 690.8893 l
374.5911 703.3893 l
f*
375.0911 690.3893 m
200.6558 690.3893 l
200.6558 690.8893 l
374.5911 690.8893 l
f*
575.9994 690.3893 m
375.0911 690.3893 l
375.0911 690.8893 l
575.9994 690.8893 l
f*
200.6558 690.3893 m
200.6558 677.8894 l
200.1557 678.3894 l
200.1557 690.3893 l
f*
200.6558 677.8894 m
36 677.8894 l
36 678.3894 l
200.1557 678.3894 l
f*
375.0911 690.3893 m
375.0911 677.8894 l
374.5911 678.3894 l
374.5911 690.3893 l
f*
375.0911 677.8894 m
200.6558 677.8894 l
200.6558 678.3894 l
374.5911 678.3894 l
f*
575.9994 677.8894 m
375.0911 677.8894 l
375.0911 678.3894 l
575.9994 678.3894 l
f*
200.6558 677.8894 m
200.6558 665.3894 l
200.1557 665.8894 l
200.1557 677.8894 l
f*
200.6558 665.3894 m
36 665.3894 l
36 665.8894 l
200.1557 665.8894 l
f*
375.0911 677.8894 m
375.0911 665.3894 l
374.5911 665.8894 l
374.5911 677.8894 l
f*
375.0911 665.3894 m
200.6558 665.3894 l
200.6558 665.8894 l
374.5911 665.8894 l
f*
575.9994 665.3894 m
375.0911 665.3894 l
375.0911 665.8894 l
575.9994 665.8894 l
f*
200.6558 665.3894 m
200.6558 652.8895 l
200.1557 653.3895 l
200.1557 665.3894 l
f*
200.6558 652.8895 m
36 652.8895 l
36 653.3895 l
200.1557 653.3895 l
f*
375.0911 665.3894 m
375.0911 652.8895 l
374.5911 653.3895 l
374.5911 665.3894 l
f*
375.0911 652.8895 m
200.6558 652.8895 l
200.6558 653.3895 l
374.5911 653.3895 l
f*
575.9994 652.8895 m
375.0911 652.8895 l
375.0911 653.3895 l
575.9994 653.3895 l
f*
200.6558 652.8895 m
200.6558 640.3895 l
200.1557 640.8896 l
200.1557 652.8895 l
f*
200.6558 640.3895 m
36 640.3895 l
36 640.8896 l
200.1557 640.8896 l
f*
375.0911 652.8895 m
375.0911 640.3895 l
374.5911 640.8896 l
374.5911 652.8895 l
f*
375.0911 640.3895 m
200.6558 640.3895 l
200.6558 640.8896 l
374.5911 640.8896 l
f*
575.9994 640.3895 m
375.0911 640.3895 l
375.0911 640.8896 l
575.9994 640.8896 l
f*
200.6558 640.3895 m
200.6558 627.8896 l
200.1557 628.3896 l
200.1557 640.3895 l
f*
200.6558 627.8896 m
36 627.8896 l
36 628.3896 l
200.1557 628.3896 l
f*
375.0911 640.3895 m
375.0911 627.8896 l
374.5911 628.3896 l
374.5911 640.3895 l
f*
375.0911 627.8896 m
200.6558 627.8896 l
200.6558 628.3896 l
374.5911 628.3896 l
f*
575.9994 627.8896 m
375.0911 627.8896 l
375.0911 628.3896 l
575.9994 628.3896 l
f*
200.6558 627.8896 m
200.6558 615.3897 l
200.1557 615.8897 l
200.1557 627.8896 l
f*
200.6558 615.3897 m
36 615.3897 l
36 615.8897 l
200.1557 615.8897 l
f*
375.0911 627.8896 m
375.0911 615.3897 l
374.5911 615.8897 l
374.5911 627.8896 l
f*
375.0911 615.3897 m
200.6558 615.3897 l
200.6558 615.8897 l
374.5911 615.8897 l
f*
575.9994 615.3897 m
375.0911 615.3897 l
375.0911 615.8897 l
575.9994 615.8897 l
f*
200.6558 615.3897 m
200.6558 602.8897 l
200.1557 603.3898 l
200.1557 615.3897 l
f*
200.6558 602.8897 m
36 602.8897 l
36 603.3898 l
200.1557 603.3898 l
f*
375.0911 615.3897 m
375.0911 602.8897 l
374.5911 603.3898 l
374.5911 615.3897 l
f*
375.0911 602.8897 m
200.6558 602.8897 l
200.6558 603.3898 l
374.5911 603.3898 l
f*
575.9994 602.8897 m
375.0911 602.8897 l
375.0911 603.3898 l
575.9994 603.3898 l
f*
200.6558 602.8897 m
200.6558 590.3898 l
200.1557 590.8898 l
200.1557 602.8897 l
f*
200.6558 590.3898 m
36 590.3898 l
36 590.8898 l
200.1557 590.8898 l
f*
375.0911 602.8897 m
375.0911 590.3898 l
374.5911 590.8898 l
374.5911 602.8897 l
f*
375.0911 590.3898 m
200.6558 590.3898 l
200.6558 590.8898 l
374.5911 590.8898 l
f*
575.9994 590.3898 m
375.0911 590.3898 l
375.0911 590.8898 l
575.9994 590.8898 l
f*
200.6558 590.3898 m
200.6558 577.8899 l
200.1557 578.3899 l
200.1557 590.3898 l
f*
200.6558 577.8899 m
36 577.8899 l
36 578.3899 l
200.1557 578.3899 l
f*
375.0911 590.3898 m
375.0911 577.8899 l
374.5911 578.3899 l
374.5911 590.3898 l
f*
375.0911 577.8899 m
200.6558 577.8899 l
200.6558 578.3899 l
374.5911 578.3899 l
f*
575.9994 577.8899 m
375.0911 577.8899 l
375.0911 578.3899 l
575.9994 578.3899 l
f*
200.6558 577.8899 m
200.6558 565.3899 l
200.1557 565.89 l
200.1557 577.8899 l
f*
200.6558 565.3899 m
36 565.3899 l
36 565.89 l
200.1557 565.89 l
f*
375.0911 577.8899 m
375.0911 565.3899 l
374.5911 565.89 l
374.5911 577.8899 l
f*
375.0911 565.3899 m
200.6558 565.3899 l
200.6558 565.89 l
374.5911 565.89 l
f*
575.9994 565.3899 m
375.0911 565.3899 l
375.0911 565.89 l
575.9994 565.89 l
f*
200.6558 565.3899 m
200.6558 552.89 l
200.1557 553.39 l
200.1557 565.3899 l
f*
200.6558 552.89 m
36 552.89 l
36 553.39 l
200.1557 553.39 l
f*
375.0911 565.3899 m
375.0911 552.89 l
374.5911 553.39 l
374.5911 565.3899 l
f*
375.0911 552.89 m
200.6558 552.89 l
200.6558 553.39 l
374.5911 553.39 l
f*
575.9994 552.89 m
375.0911 552.89 l
375.0911 553.39 l
575.9994 553.39 l
f*
200.6558 552.89 m
200.6558 540.39 l
200.1557 540.8901 l
200.1557 552.89 l
f*
200.6558 540.39 m
36 540.39 l
36 540.8901 l
200.1557 540.8901 l
f*
375.0911 552.89 m
375.0911 540.39 l
374.5911 540.8901 l
374.5911 552.89 l
f*
375.0911 540.39 m
200.6558 540.39 l
200.6558 540.8901 l
374.5911 540.8901 l
f*
575.9994 540.39 m
375.0911 540.39 l
375.0911 540.8901 l
575.9994 540.8901 l
f*
0 g
7.9999 0 0 7.9999 36 708.7181 cm
BT
/F3 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Table)Tj
2.7992 0 Td
(1.)Tj
1.2614 0 Td
(Baseline)Tj
4.2733 0 Td
(characte)Tj
4.0394 0 Td
(ristics)Tj
3.111 0 Td
(of)Tj
1.1552 0 Td
(the)Tj
1.7008 0 Td
(study)Tj
2.8559 0 Td
(population)Tj
5.0669 0 Td
(s)Tj
0.7654 0 Td
(in)Tj
1.1055 0 Td
(the)Tj
1.7008 0 Td
(ANRS)Tj
3.0119 0 Td
(HB03)Tj
2.7354 0 Td
(VIHVAC)Tj
3.9473 0 Td
(B)Tj
0.9354 0 Td
(trial)Tj
2.0197 0 Td
(and)Tj
1.9772 0 Td
(the)Tj
1.7008 0 Td
(ANRS)Tj
3.0189 0 Td
(114-PN)Tj
3.3308 0 Td
(EUMOVAC)Tj
5.2725 0 Td
(sub-study.)Tj
0 Tc
-34.7176 -1.8567 Td
(ANRS)Tj
3.0472 0 Td
(HB03)Tj
2.7638 0 Td
(VIHVAC)Tj
3.9898 0 Td
(B)Tj
0.9426 0 Td
(trial)Tj
2.0551 0 Td
(\(n)Tj
1.1764 0 Td
(=)Tj
0.8149 0 Td
(339\))Tj
7.0158 0 Td
(ANRS)Tj
3.0473 0 Td
(114-PN)Tj
3.3591 0 Td
(EUMOVAC)Tj
5.3221 0 Td
(sub-stu)Tj
3.6 0 Td
(dy)Tj
1.3961 0 Td
(\(n)Tj
1.1764 0 Td
(=)Tj
0.8079 0 Td
(25\))Tj
/F0 1 Tf
-63.5816 -1.6228 Td
(Age)Tj
1.9984 0 Td
(\(years\))Tj
3.0898 0 Td
(,)Tj
0.5102 0 Td
(median,)Tj
3.763 0 Td
(IQR)Tj
19.7152 0 Td
(43)Tj
1.3323 0 Td
(\(3649\))Tj
22.16 0 Td
(43)Tj
1.3323 0 Td
(\(3650\))Tj
-53.9012 -1.5591 Td
(Male)Tj
2.3811 0 Td
(sex,)Tj
2.0551 0 Td
(n,)Tj
1.063 0 Td
(%)Tj
24.1301 0 Td
(229)Tj
1.8851 0 Td
(\(68\))Tj
21.8836 0 Td
(17)Tj
1.3252 0 Td
(\(68\))Tj
-54.7232 -1.5661 Td
(On)Tj
1.559 0 Td
(antiretrovi)Tj
4.3583 0 Td
(ral)Tj
1.3323 0 Td
(treatment,)Tj
4.7197 0 Td
(n,)Tj
1.0559 0 Td
(%)Tj
16.6041 0 Td
(261)Tj
1.8851 0 Td
(\(77\))Tj
21.8836 0 Td
(23)Tj
1.3252 0 Td
(\(92\))Tj
-54.7232 -1.5591 Td
(CD4)Tj
2.211 0 Td
(count)Tj
2.6646 0 Td
(\(cells/m)Tj
3.4228 0 Td
(m)Tj
ET
Q
q
1 j
1 J
0 w
5.9998 0 0 5.3325 109.0204 646.9228 cm
BT
/F0 1 Tf
1 TL
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
7.9999 0 0 7.9999 112.3653 643.4078 cm
BT
/F0 1 Tf
1 TL
0 0 Td
(\),)Tj
0.8433 0 Td
(median)Tj
3.2457 0 Td
(,)Tj
0.5102 0 Td
(IQR)Tj
14.1096 0 Td
(508)Tj
1.8779 0 Td
(\(401658\))Tj
21.6144 0 Td
(375)Tj
1.8779 0 Td
(\(302405\))Tj
-53.6247 -1.5661 Td
(HIV-1)Tj
2.7709 0 Td
(RNA)Tj
2.3315 0 Td
(level)Tj
/F9 1 Tf
2.2677 0 Td
[( )]TJ
/F0 1 Tf
0.8079 0 Td
(500)Tj
1.8779 0 Td
(cp/mL,)Tj
3.2244 0 Td
(n,)Tj
1.063 0 Td
(%)Tj
15.286 0 Td
(295)Tj
1.885 0 Td
(\(87\))Tj
21.8837 0 Td
(20)Tj
1.3252 0 Td
(\(80\))Tj
-54.7232 -1.5591 Td
(CDC)Tj
2.3811 0 Td
(category)Tj
4.0394 0 Td
(C,)Tj
1.226 0 Td
(n,)Tj
1.063 0 Td
(%)Tj
21.1962 0 Td
(46)Tj
1.3322 0 Td
(\(14\))Tj
22.1601 0 Td
(13)Tj
1.3252 0 Td
(\(52\))Tj
-54.7232 -1.5661 Td
(Active)Tj
2.941 0 Td
(smoking,)Tj
4.2095 0 Td
(n,)Tj
1.0559 0 Td
(%)Tj
21.4229 0 Td
(109)Tj
1.885 0 Td
(\(32\))Tj
22.153 0 Td
(9)Tj
0.7866 0 Td
(\(36\))Tj
-54.4539 -1.5591 Td
(25OHD)Tj
3.5433 0 Td
(level)Tj
2.2678 0 Td
(\(ng/mL)Tj
3.0898 0 Td
(\),)Tj
0.8432 0 Td
(median,)Tj
3.763 0 Td
(IQR)Tj
15.5694 0 Td
(18)Tj
1.3323 0 Td
(\(1225\))Tj
22.16 0 Td
(24)Tj
1.3323 0 Td
(\(1332\))Tj
-53.9011 -1.5661 Td
(25OHD)Tj
3.5433 0 Td
(status,)Tj
3.1678 0 Td
(n,)Tj
1.063 0 Td
(%)Tj
-7.3135 -1.5591 Td
(Sufcienc)Tj
4.3087 0 Td
(y)Tj
0.73 0 Td
(\()Tj
/F17 1 Tf
()Tj
/F0 1 Tf
1.3323 0 Td
(30)Tj
1.3252 0 Td
(ng/mL\))Tj
21.7489 0 Td
(57)Tj
1.3322 0 Td
(\(17\))Tj
22.4294 0 Td
(8)Tj
0.7866 0 Td
(\(32\))Tj
-53.9933 -1.5662 Td
(Insufcien)Tj
4.4717 0 Td
(cy)Tj
1.2331 0 Td
(\(1029)Tj
3.3095 0 Td
(ng/mL\))Tj
20.1544 0 Td
(236)Tj
1.885 0 Td
(\(70\))Tj
21.8837 0 Td
(14)Tj
1.3252 0 Td
(\(56\))Tj
-54.2626 -1.559 Td
(Decien)Tj
3.5788 0 Td
(cy)Tj
1.2331 0 Td
(\()Tj
/F9 1 Tf
[( )]TJ
/F0 1 Tf
1.1409 0 Td
(10)Tj
1.3323 0 Td
(ng/mL\))Tj
22.16 0 Td
(46)Tj
1.3322 0 Td
(\(13\))Tj
22.4294 0 Td
(3)Tj
0.7866 0 Td
(\(12\))Tj
/F11 1 Tf
-0.005 Tc
-54.4539 -1.878 Td
(doi:)Tj
-0.025 Tc
(10.137)Tj
4.0323 0 Td
(1/journal.pone.)Tj
5.5559 0 Td
(0168640.t)Tj
3.7913 0 Td
(001)Tj
ET
Q
q
0.45 0.36 0.35 0.01 k
1 j
1 J
0 w
36 192.2525 m
576 192.2525 l
576 191.7524 l
36 191.7524 l
f*
145.7603 191.7524 m
145.7603 178.7525 l
145.2603 179.2525 l
145.2603 191.7524 l
f*
145.7603 178.7525 m
36 178.7525 l
36 179.2525 l
145.2603 179.2525 l
f*
275.2875 191.7524 m
275.2875 178.7525 l
274.7874 179.2525 l
274.7874 191.7524 l
f*
275.2875 178.7525 m
145.7603 178.7525 l
145.7603 179.2525 l
274.7874 179.2525 l
f*
403.4854 191.7524 m
403.4854 178.7525 l
402.9854 179.2525 l
402.9854 191.7524 l
f*
403.4854 178.7525 m
275.2875 178.7525 l
275.2875 179.2525 l
402.9854 179.2525 l
f*
539.6581 191.7524 m
539.6581 178.7525 l
539.1581 179.2525 l
539.1581 191.7524 l
f*
539.6581 178.7525 m
403.4854 178.7525 l
403.4854 179.2525 l
539.1581 179.2525 l
f*
575.9997 178.7525 m
539.6581 178.7525 l
539.6581 179.2525 l
575.9997 179.2525 l
f*
145.7603 178.7525 m
145.7603 166.2525 l
145.2603 166.7526 l
145.2603 178.7525 l
f*
145.7603 166.2525 m
36 166.2525 l
36 166.7526 l
145.2603 166.7526 l
f*
275.2875 178.7525 m
275.2875 166.2525 l
274.7874 166.7526 l
274.7874 178.7525 l
f*
275.2875 166.2525 m
145.7603 166.2525 l
145.7603 166.7526 l
274.7874 166.7526 l
f*
403.4854 178.7525 m
403.4854 166.2525 l
402.9854 166.7526 l
402.9854 178.7525 l
f*
403.4854 166.2525 m
275.2875 166.2525 l
275.2875 166.7526 l
402.9854 166.7526 l
f*
539.6581 178.7525 m
539.6581 166.2525 l
539.1581 166.7526 l
539.1581 178.7525 l
f*
539.6581 166.2525 m
403.4854 166.2525 l
403.4854 166.7526 l
539.1581 166.7526 l
f*
575.9997 166.2525 m
539.6581 166.2525 l
539.6581 166.7526 l
575.9997 166.7526 l
f*
145.7603 166.2525 m
145.7603 153.7526 l
145.2603 154.2526 l
145.2603 166.2525 l
f*
145.7603 153.7526 m
36 153.7526 l
36 154.2526 l
145.2603 154.2526 l
f*
275.2875 166.2525 m
275.2875 153.7526 l
274.7874 154.2526 l
274.7874 166.2525 l
f*
275.2875 153.7526 m
145.7603 153.7526 l
145.7603 154.2526 l
274.7874 154.2526 l
f*
403.4854 166.2525 m
403.4854 153.7526 l
402.9854 154.2526 l
402.9854 166.2525 l
f*
403.4854 153.7526 m
275.2875 153.7526 l
275.2875 154.2526 l
402.9854 154.2526 l
f*
539.6581 166.2525 m
539.6581 153.7526 l
539.1581 154.2526 l
539.1581 166.2525 l
f*
539.6581 153.7526 m
403.4854 153.7526 l
403.4854 154.2526 l
539.1581 154.2526 l
f*
575.9997 153.7526 m
539.6581 153.7526 l
539.6581 154.2526 l
575.9997 154.2526 l
f*
145.7603 153.7526 m
145.7603 141.2527 l
145.2603 141.7527 l
145.2603 153.7526 l
f*
145.7603 141.2527 m
36 141.2527 l
36 141.7527 l
145.2603 141.7527 l
f*
275.2875 153.7526 m
275.2875 141.2527 l
274.7874 141.7527 l
274.7874 153.7526 l
f*
275.2875 141.2527 m
145.7603 141.2527 l
145.7603 141.7527 l
274.7874 141.7527 l
f*
403.4854 153.7526 m
403.4854 141.2527 l
402.9854 141.7527 l
402.9854 153.7526 l
f*
403.4854 141.2527 m
275.2875 141.2527 l
275.2875 141.7527 l
402.9854 141.7527 l
f*
539.6581 153.7526 m
539.6581 141.2527 l
539.1581 141.7527 l
539.1581 153.7526 l
f*
539.6581 141.2527 m
403.4854 141.2527 l
403.4854 141.7527 l
539.1581 141.7527 l
f*
575.9997 141.2527 m
539.6581 141.2527 l
539.6581 141.7527 l
575.9997 141.7527 l
f*
145.7603 141.2527 m
145.7603 128.7527 l
145.2603 129.2528 l
145.2603 141.2527 l
f*
145.7603 128.7527 m
36 128.7527 l
36 129.2528 l
145.2603 129.2528 l
f*
275.2875 141.2527 m
275.2875 128.7527 l
274.7874 129.2528 l
274.7874 141.2527 l
f*
275.2875 128.7527 m
145.7603 128.7527 l
145.7603 129.2528 l
274.7874 129.2528 l
f*
403.4854 141.2527 m
403.4854 128.7527 l
402.9854 129.2528 l
402.9854 141.2527 l
f*
403.4854 128.7527 m
275.2875 128.7527 l
275.2875 129.2528 l
402.9854 129.2528 l
f*
539.6581 141.2527 m
539.6581 128.7527 l
539.1581 129.2528 l
539.1581 141.2527 l
f*
539.6581 128.7527 m
403.4854 128.7527 l
403.4854 129.2528 l
539.1581 129.2528 l
f*
575.9997 128.7527 m
539.6581 128.7527 l
539.6581 129.2528 l
575.9997 129.2528 l
f*
575.9997 95.0026 m
36 95.0026 l
36 95.5026 l
575.9997 95.5026 l
f*
0 g
7.9999 0 0 7.9999 36 197.0645 cm
BT
/F3 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Table)Tj
2.7992 0 Td
(2.)Tj
1.2614 0 Td
(Association)Tj
5.8182 0 Td
(between)Tj
4.1669 0 Td
(baseline)Tj
4.167 0 Td
(25OH)Tj
2.7992 0 Td
(Vitamin)Tj
3.7843 0 Td
(D)Tj
0.9354 0 Td
(status)Tj
3.1182 0 Td
(and)Tj
1.9772 0 Td
(response)Tj
4.6063 0 Td
(to)Tj
1.1551 0 Td
(hepatiti)Tj
3.5079 0 Td
(s)Tj
0.7654 0 Td
(B)Tj
0.9354 0 Td
(vaccinat)Tj
3.9331 0 Td
(ion)Tj
1.715 0 Td
(in)Tj
1.1055 0 Td
(the)Tj
1.6937 0 Td
(ANRS)Tj
3.019 0 Td
(HB03)Tj
2.7283 0 Td
(VIHVAC)Tj
3.9544 0 Td
(B)Tj
0.9283 0 Td
(trial)Tj
2.0268 0 Td
(\(n)Tj
1.1552 0 Td
(=)Tj
0.7937 0 Td
(339\).)Tj
0 Tc
-50.8823 -1.8496 Td
(Vaccine)Tj
3.9898 0 Td
(non)Tj
2.0693 0 Td
(respond)Tj
3.9331 0 Td
(ers)Tj
1.715 0 Td
(\(n)Tj
1.1763 0 Td
(=)Tj
0.815 0 Td
(52\))Tj
2.4945 0 Td
(Vaccine)Tj
3.9898 0 Td
(low)Tj
1.8992 0 Td
(responder)Tj
4.8686 0 Td
(s)Tj
0.7866 0 Td
(\(n)Tj
1.1693 0 Td
(=)Tj
0.815 0 Td
(61\))Tj
2.4945 0 Td
(Vaccine)Tj
3.9898 0 Td
(high)Tj
2.3527 0 Td
(respon)Tj
3.3166 0 Td
(ders)Tj
2.3315 0 Td
(\(n)Tj
1.1764 0 Td
(=)Tj
0.8079 0 Td
(226\))Tj
/F19 1 Tf
3.0473 0 Td
(P)Tj
/F3 1 Tf
(-value)Tj
/F0 1 Tf
-63.206 -1.6299 Td
(Baseline)Tj
4.0323 0 Td
(25OHD)Tj
3.5433 0 Td
(status,)Tj
3.1677 0 Td
(n,)Tj
1.056 0 Td
(%)Tj
52.4626 0 Td
(0.09)Tj
-63.3407 -1.5591 Td
(Sufcienc)Tj
4.3087 0 Td
(y)Tj
0.7299 0 Td
(\()Tj
/F17 1 Tf
()Tj
/F0 1 Tf
1.3252 0 Td
(30)Tj
1.3323 0 Td
(ng/mL\))Tj
11.1757 0 Td
(11)Tj
1.3323 0 Td
(\(21%\))Tj
14.7757 0 Td
(14)Tj
1.3323 0 Td
(\(23%\))Tj
15.1938 0 Td
(32)Tj
1.3323 0 Td
(\(14%\))Tj
-52.8382 -1.5661 Td
(Insufcien)Tj
4.4717 0 Td
(cy)Tj
1.226 0 Td
(\(1029)Tj
3.3166 0 Td
(ng/mL\))Tj
9.8575 0 Td
(39)Tj
1.3323 0 Td
(\(75%\))Tj
14.7757 0 Td
(39)Tj
1.3323 0 Td
(\(64%\))Tj
14.9175 0 Td
(158)Tj
1.8779 0 Td
(\(70%\))Tj
-53.1075 -1.5591 Td
(Decien)Tj
3.5788 0 Td
(cy)Tj
1.226 0 Td
(\()Tj
/F9 1 Tf
[( )]TJ
/F0 1 Tf
1.148 0 Td
(10)Tj
1.3323 0 Td
(ng/mL\))Tj
12.1395 0 Td
(2)Tj
0.7795 0 Td
(\(4%\))Tj
15.0521 0 Td
(8)Tj
0.7795 0 Td
(\(13%\))Tj
15.4702 0 Td
(36)Tj
1.3323 0 Td
(\(16%\))Tj
-53.7594 -2.3457 Td
(Vaccine)Tj
3.763 0 Td
(non)Tj
1.8779 0 Td
(responde)Tj
4.1316 0 Td
(rs:)Tj
1.3464 0 Td
(anti-HBs)Tj
/F17 1 Tf
4.0394 0 Td
()Tj
/F0 1 Tf
0.9993 0 Td
(10)Tj
1.3252 0 Td
(mIU/mL;)Tj
4.0039 0 Td
(vaccine)Tj
3.593 0 Td
(low)Tj
1.7149 0 Td
(respond)Tj
3.5788 0 Td
(ers:)Tj
1.8922 0 Td
(10)Tj
1.3323 0 Td
(mIU/mL)Tj
/F9 1 Tf
3.7205 0 Td
[( )]TJ
/F0 1 Tf
0.8078 0 Td
(anti-HBs)Tj
/F17 1 Tf
4.0465 0 Td
()Tj
/F0 1 Tf
0.9992 0 Td
(100)Tj
1.878 0 Td
(mIU/mL;)Tj
3.9969 0 Td
(vaccine)Tj
3.5929 0 Td
(high)Tj
2.1048 0 Td
(respond)Tj
3.5787 0 Td
(ers:)Tj
1.8922 0 Td
(anti-HBs)Tj
/F9 1 Tf
4.0394 0 Td
[( !)]TJ
/F0 1 Tf
0.815 0 Td
(100)Tj
-65.0698 -1.4953 Td
(mIU/mL)Tj
/F11 1 Tf
-0.005 Tc
0 -2.2535 Td
(doi:)Tj
-0.025 Tc
(10.137)Tj
4.0323 0 Td
(1/journal.pone.)Tj
5.5559 0 Td
(0168640.t)Tj
3.7914 0 Td
(002)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 379.6157 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.4937 0 Td
(D)Tj
0.9354 0 Td
(and)Tj
1.8567 0 Td
(Vaccine)Tj
3.7134 0 Td
(Response)Tj
4.4221 0 Td
(s)Tj
0.7158 0 Td
(in)Tj
0.9779 0 Td
(HIV-Infected)Tj
5.6977 0 Td
(Adults)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(640)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(15,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(5)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
93 0 obj
<>stream
endstream
endobj
94 0 obj
<>stream
endstream
endobj
95 0 obj
<>stream
endstream
endobj
96 0 obj
<>stream
endstream
endobj
97 0 obj
<>stream
endstream
endobj
98 0 obj
<>stream
BT
66.402 0 Td
(10)Tj
ET
Q
endstream
endobj
99 0 obj
<>/ColorSpace<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 102 0 R/Contents 103 0 R/TrimBox[0 0 612 792]>>
endobj
101 0 obj
[/ICCBased 104 0 R]
endobj
104 0 obj
<>stream
xwTSϽ7PkhRH
H.*1 J "6DTpDQ2(C"QDqpIdy͛~kg}ֺ LX Xňg` l pBF|،l *? Y"1 P\8=W%Oɘ4M0J"Y2Vs,[|e92<se'9`2&ctI@o|N6 (.sSdl-c(2-y H_/XZ.$&\SM07#1ؙYr fYym";8980m-m(]v^DW~
emi ]P`/ u}q|^R,g+\Kk)/C_|Rax8t1C^7nfzDp柇u$/ED˦L L[B@ٹЖX!@~ (* {d+}G͋љς}WL$cGD2QZ4 E@@ A(q`1D `'u46ptc48.`R0)
@Rt CXCP%CBH@Rf[(t
CQhz#0 Zl`O828.p|O×X
?:0FBx$ !i@ڐH[EE1PL⢖V6QP>U(j
MFk t,:.FW8c1L&ӎ9ƌaX:
rbl1
{{{;}#tp8_\8"Ey.,X%%Gщ1-9ҀKl.oo/O$&'=JvMޞ